This regulatory network was inferred from the input dataset. The miRNAs and mRNAs are
presented as round and rectangle nodes respectively. The numerical value popped up upon mouse over the gene node is the log2 transformed fold-change of the gene expression between the two groups. All of the nodes are clickable, and the detailed information of the miRNAs/mRNAs and related cancer pathway will be displayed in another window. The edges between nodes are supported by both interactions (predicted or experimentally verified) and correlations learnt from cancer dataset. The numerical value popped up upon mouse over the edge is the correlation beat value (effect size) between the two nodes. The experimental evidences of the edges reported in previous cancer studies are highlighted by red/orange color. All of these information can be accessed by the "mouse-over" action. This network shows a full map of the miRNA-mRNA regulation of the input gene list(s), and the hub miRNAs (with the high network degree/betweenness centrality) would be the potential cancer drivers or tumor suppressors. The full result table can be accessed in the "Regulations" tab.
"miRNACancerMAP" is also a network visualization tool for users to draw their regulatory network by personal customization. Users can set the complexity of the network by limiting the number of nodes or edges. And the color of the nodes can be defined by different categories of the mRNAs and miRNAs, such as Gene-Ontology, pathway, and expression status. Users can also select to use network degree or network betweenness centrality to define the node size. And edges can be black or colored by the correlation. Purple edge means negative correlation (mostly found between miRNA and mRNA), and blue edge means positive correlation (found in PPI or miRNA-miRNA sponge effect). We can also add the protein-protein interactions (PPI) into the network. This result will show the cluster of genes regulated by some specific miRNAs. Additionally, miRNA-miRNA edges can be added by the "miRNA sponge" button, presenting some clusters of miRNAs that have the interactions via sponge effect.
Num | microRNA | Gene | miRNA log2FC | miRNA pvalue | Gene log2FC | Gene pvalue | Interaction | Correlation beta | Correlation P-value | PMID | Reported in cancer studies |
---|---|---|---|---|---|---|---|---|---|---|---|
1 | hsa-miR-15b-3p | ABCA1 | 3.58 | 0 | 0.72 | 0.28064 | mirMAP | -0.19 | 0.00433 | NA | |
2 | hsa-miR-106b-5p | ABCD2 | 2.81 | 0 | -2.82 | 0.00416 | MirTarget | -0.5 | 2.0E-5 | NA | |
3 | hsa-miR-21-3p | ABI2 | 3.5 | 0 | -1.23 | 0.00252 | MirTarget | -0.2 | 0 | NA | |
4 | hsa-miR-15b-3p | ABL1 | 3.58 | 0 | -1.72 | 0 | MirTarget | -0.13 | 0.00015 | NA | |
5 | hsa-miR-15b-5p | ABL1 | 3.32 | 0 | -1.72 | 0 | mirMAP | -0.11 | 0.00854 | NA | |
6 | hsa-miR-21-3p | ACAD11 | 3.5 | 0 | -0.47 | 0.21913 | MirTarget | -0.14 | 0.0002 | NA | |
7 | hsa-miR-15b-3p | ACADSB | 3.58 | 0 | -1.51 | 0.00314 | mirMAP | -0.18 | 0.00045 | NA | |
8 | hsa-miR-21-5p | ACAT1 | 2.65 | 0 | -1.94 | 1.0E-5 | miRNAWalker2 validate | -0.34 | 1.0E-5 | NA | |
9 | hsa-miR-125a-3p | ACPP | -0.07 | 0.92074 | 3.93 | 3.0E-5 | MirTarget; miRanda | -0.32 | 1.0E-5 | NA | |
10 | hsa-miR-125a-5p | ACPP | -1.32 | 0.00714 | 3.93 | 3.0E-5 | MirTarget; miRanda | -0.27 | 0.0146 | NA | |
11 | hsa-miR-192-5p | ACPP | 1.78 | 0.11349 | 3.93 | 3.0E-5 | MirTarget | -0.1 | 0.03284 | NA | |
12 | hsa-miR-326 | ACPP | 1.77 | 0.03673 | 3.93 | 3.0E-5 | miRanda | -0.13 | 0.04646 | NA | |
13 | hsa-miR-491-5p | ACPP | 0.57 | 0.31331 | 3.93 | 3.0E-5 | miRanda | -0.31 | 0.00154 | NA | |
14 | hsa-miR-21-5p | ACVR2A | 2.65 | 0 | -0.45 | 0.27609 | miRNATAP | -0.24 | 0.0004 | NA | |
15 | hsa-miR-106b-5p | ADAM19 | 2.81 | 0 | 0.44 | 0.52629 | mirMAP | -0.18 | 0.03423 | NA | |
16 | hsa-miR-106b-5p | ADAM9 | 2.81 | 0 | 0.33 | 0.49553 | miRNATAP | -0.13 | 0.02564 | NA | |
17 | hsa-miR-15b-3p | ADAMTS19 | 3.58 | 0 | -8.36 | 0 | MirTarget | -0.76 | 0 | NA | |
18 | hsa-miR-106b-3p | ADAMTS2 | 2.58 | 0 | -2.49 | 0.0191 | miRNAWalker2 validate | -0.56 | 1.0E-5 | NA | |
19 | hsa-miR-106b-5p | ADAMTS5 | 2.81 | 0 | -6.22 | 0 | miRNATAP | -0.56 | 0 | NA | |
20 | hsa-miR-15b-3p | ADAMTS5 | 3.58 | 0 | -6.22 | 0 | mirMAP | -0.54 | 0 | NA | |
21 | hsa-miR-15b-5p | ADAMTS5 | 3.32 | 0 | -6.22 | 0 | miRNATAP | -0.67 | 0 | NA | |
22 | hsa-miR-15b-5p | ADAMTSL3 | 3.32 | 0 | -3.54 | 0.01144 | MirTarget | -0.37 | 0.02838 | NA | |
23 | hsa-miR-21-3p | ADCY1 | 3.5 | 0 | -1.34 | 0.20446 | mirMAP | -0.2 | 0.04982 | NA | |
24 | hsa-miR-21-5p | ADCY2 | 2.65 | 0 | -5.74 | 0.00019 | MirTarget | -1.02 | 8.0E-5 | NA | |
25 | hsa-miR-21-3p | ADCY6 | 3.5 | 0 | -0.74 | 0.15175 | mirMAP | -0.16 | 0.0012 | NA | |
26 | hsa-miR-106b-5p | ADRA2A | 2.81 | 0 | -3.42 | 0.00512 | miRNATAP | -0.75 | 0 | NA | |
27 | hsa-miR-15b-3p | AFF2 | 3.58 | 0 | -0.5 | 0.77135 | mirMAP | -0.37 | 0.03368 | NA | |
28 | hsa-miR-21-3p | AFF2 | 3.5 | 0 | -0.5 | 0.77135 | mirMAP | -0.42 | 0.01215 | NA | |
29 | hsa-miR-15b-3p | AFF4 | 3.58 | 0 | -0.54 | 0.12416 | mirMAP | -0.1 | 0.00391 | NA | |
30 | hsa-miR-21-3p | AFF4 | 3.5 | 0 | -0.54 | 0.12416 | mirMAP | -0.13 | 0.0002 | NA | |
31 | hsa-miR-15b-5p | AGAP3 | 3.32 | 0 | -0.6 | 0.12108 | miRNATAP | -0.13 | 0.00452 | NA | |
32 | hsa-miR-15b-5p | AGPAT4 | 3.32 | 0 | -1.78 | 0.03177 | mirMAP | -0.28 | 0.00483 | NA | |
33 | hsa-miR-15b-5p | AHCYL2 | 3.32 | 0 | -0.37 | 0.48866 | miRNATAP | -0.13 | 0.0367 | NA | |
34 | hsa-miR-106b-5p | AHNAK | 2.81 | 0 | -1.19 | 0.03091 | miRNATAP | -0.28 | 2.0E-5 | NA | |
35 | hsa-miR-15b-5p | AHRR | 3.32 | 0 | -0.32 | 0.65958 | mirMAP | -0.29 | 0.00084 | NA | |
36 | hsa-miR-338-3p | AIM2 | 0.45 | 0.55849 | 5.33 | 0.00329 | miRanda | -0.5 | 0.0002 | NA | |
37 | hsa-miR-106b-5p | AKAP11 | 2.81 | 0 | -0.61 | 0.12508 | miRNAWalker2 validate | -0.19 | 5.0E-5 | NA | |
38 | hsa-miR-15b-5p | AKAP11 | 3.32 | 0 | -0.61 | 0.12508 | MirTarget; miRNATAP | -0.1 | 0.02999 | NA | |
39 | hsa-miR-21-3p | AKAP11 | 3.5 | 0 | -0.61 | 0.12508 | MirTarget | -0.15 | 0.00012 | NA | |
40 | hsa-miR-106b-5p | AKAP13 | 2.81 | 0 | -1.49 | 0.00023 | MirTarget; mirMAP; miRNATAP | -0.24 | 0 | NA | |
41 | hsa-miR-99a-5p | AKAP2 | -2.72 | 0.00622 | -3.13 | 0.04037 | miRNAWalker2 validate | -0.19 | 0.02556 | NA | |
42 | hsa-miR-21-5p | AKAP6 | 2.65 | 0 | -2.97 | 1.0E-5 | MirTarget | -0.47 | 4.0E-5 | NA | |
43 | hsa-miR-21-5p | AKIRIN1 | 2.65 | 0 | -0.18 | 0.57276 | miRNATAP | -0.14 | 0.01113 | NA | |
44 | hsa-miR-106b-5p | AKT3 | 2.81 | 0 | -3.33 | 1.0E-5 | miRNATAP | -0.41 | 1.0E-5 | NA | |
45 | hsa-miR-15b-5p | AKT3 | 3.32 | 0 | -3.33 | 1.0E-5 | miRNATAP | -0.25 | 0.00571 | NA | |
46 | hsa-miR-125a-3p | ALOX12 | -0.07 | 0.92074 | 3.5 | 0.02136 | miRanda | -0.37 | 0.00117 | NA | |
47 | hsa-miR-21-5p | ALX1 | 2.65 | 0 | -3.17 | 0.07094 | MirTarget; miRNATAP | -1.01 | 0.00061 | NA | |
48 | hsa-miR-21-3p | AMOT | 3.5 | 0 | -1.94 | 0.20701 | mirMAP | -0.74 | 0 | NA | |
49 | hsa-miR-15b-5p | AMOTL1 | 3.32 | 0 | -0.99 | 0.1814 | MirTarget; miRNATAP | -0.28 | 0.00162 | NA | |
50 | hsa-miR-106b-5p | ANK2 | 2.81 | 0 | -5.41 | 0 | MirTarget; miRNATAP | -0.77 | 0 | NA | |
51 | hsa-miR-15b-5p | ANK2 | 3.32 | 0 | -5.41 | 0 | MirTarget; miRNATAP | -0.63 | 0 | NA | |
52 | hsa-miR-106b-5p | ANKRD12 | 2.81 | 0 | -0.49 | 0.18892 | MirTarget | -0.11 | 0.02006 | NA | |
53 | hsa-miR-106b-5p | ANKRD29 | 2.81 | 0 | -2.36 | 0.04103 | MirTarget | -0.35 | 0.01138 | NA | |
54 | hsa-miR-21-5p | ANKRD46 | 2.65 | 0 | -1.15 | 0.00253 | miRNAWalker2 validate; miRTarBase | -0.36 | 0 | 21219636 | Knockdown of miR-21 significantly increased the expression of ANKRD46 at both mRNA and protein levels; ANKRD46 is newly identified as a direct target of miR-21 in BC |
55 | hsa-miR-106b-5p | ANKRD50 | 2.81 | 0 | -0.02 | 0.97181 | MirTarget; miRNATAP | -0.2 | 0.00277 | NA | |
56 | hsa-miR-21-5p | ANKS1B | 2.65 | 0 | -3.57 | 0.00191 | MirTarget | -0.65 | 0.00078 | NA | |
57 | hsa-miR-21-5p | ANO3 | 2.65 | 0 | -3.4 | 0.00628 | mirMAP | -0.51 | 0.01584 | NA | |
58 | hsa-miR-106b-5p | ANO6 | 2.81 | 0 | -1.42 | 0.00017 | MirTarget | -0.22 | 0 | NA | |
59 | hsa-miR-21-5p | ANP32A | 2.65 | 0 | 0.42 | 0.14232 | miRNAWalker2 validate; miRTarBase | -0.13 | 0.00777 | NA | |
60 | hsa-miR-15b-3p | ANTXR1 | 3.58 | 0 | -1.72 | 0.01008 | mirMAP | -0.31 | 0 | NA | |
61 | hsa-miR-15b-3p | ANTXR2 | 3.58 | 0 | -4.25 | 0 | mirMAP | -0.38 | 0 | NA | |
62 | hsa-miR-99a-5p | AP2B1 | -2.72 | 0.00622 | -0.74 | 0.27055 | miRNAWalker2 validate | -0.16 | 2.0E-5 | NA | |
63 | hsa-miR-106b-5p | APBB2 | 2.81 | 0 | -1.53 | 0.00158 | MirTarget; miRNATAP | -0.12 | 0.0483 | NA | |
64 | hsa-miR-15b-3p | APBB2 | 3.58 | 0 | -1.53 | 0.00158 | mirMAP | -0.18 | 0.00024 | NA | |
65 | hsa-miR-15b-5p | APLNR | 3.32 | 0 | -1.37 | 0.09928 | MirTarget | -0.42 | 1.0E-5 | NA | |
66 | hsa-miR-335-5p | APOC1 | 0.17 | 0.8039 | 3.77 | 0.00044 | miRNAWalker2 validate | -0.19 | 0.03662 | NA | |
67 | hsa-miR-21-5p | APOLD1 | 2.65 | 0 | -3.29 | 0 | miRNAWalker2 validate | -0.52 | 0 | NA | |
68 | hsa-miR-21-5p | APPL1 | 2.65 | 0 | -0.45 | 0.2173 | miRNAWalker2 validate | -0.13 | 0.03081 | NA | |
69 | hsa-miR-106b-5p | AR | 2.81 | 0 | -4.57 | 0.00169 | mirMAP | -0.67 | 0.00014 | NA | |
70 | hsa-miR-15b-5p | AR | 3.32 | 0 | -4.57 | 0.00169 | mirMAP; miRNATAP | -0.34 | 0.04943 | NA | |
71 | hsa-miR-106b-5p | ARHGAP1 | 2.81 | 0 | -0.85 | 0.00369 | MirTarget; miRNATAP | -0.18 | 0 | NA | |
72 | hsa-miR-15b-5p | ARHGAP20 | 3.32 | 0 | -3.56 | 0.00051 | MirTarget; miRNATAP | -0.54 | 1.0E-5 | NA | |
73 | hsa-miR-106b-5p | ARHGAP23 | 2.81 | 0 | 0.12 | 0.89085 | mirMAP | -0.35 | 0.00083 | NA | |
74 | hsa-miR-21-5p | ARHGAP24 | 2.65 | 0 | -1.64 | 0.06301 | MirTarget; miRNATAP | -0.45 | 0.00219 | NA | |
75 | hsa-miR-15b-3p | ARHGAP28 | 3.58 | 0 | -2.52 | 0.04263 | mirMAP | -0.44 | 0.00051 | NA | |
76 | hsa-miR-15b-3p | ARHGAP32 | 3.58 | 0 | 0.91 | 0.12572 | mirMAP | -0.21 | 0.00032 | NA | |
77 | hsa-miR-15b-5p | ARHGAP32 | 3.32 | 0 | 0.91 | 0.12572 | MirTarget | -0.2 | 0.00409 | NA | |
78 | hsa-miR-21-3p | ARHGAP6 | 3.5 | 0 | -5.45 | 0 | MirTarget | -0.63 | 0 | NA | |
79 | hsa-miR-15b-5p | ARHGEF12 | 3.32 | 0 | -0.4 | 0.28538 | MirTarget | -0.12 | 0.00731 | NA | |
80 | hsa-miR-106b-5p | ARHGEF3 | 2.81 | 0 | -1 | 0.016 | MirTarget; miRNATAP | -0.16 | 0.00129 | NA | |
81 | hsa-miR-106b-5p | ARID4A | 2.81 | 0 | -0.65 | 0.04997 | MirTarget; miRNATAP | -0.12 | 0.00297 | NA | |
82 | hsa-miR-21-5p | ARL1 | 2.65 | 0 | -0.8 | 0.00239 | MirTarget | -0.2 | 0 | NA | |
83 | hsa-miR-21-3p | ARL10 | 3.5 | 0 | -0.75 | 0.35282 | mirMAP | -0.24 | 0.00274 | NA | |
84 | hsa-miR-21-5p | ARMCX1 | 2.65 | 0 | -4.07 | 0 | MirTarget | -0.38 | 0.00829 | NA | |
85 | hsa-miR-21-5p | ARMCX3 | 2.65 | 0 | -1.48 | 0.02356 | miRNAWalker2 validate | -0.37 | 0.00077 | NA | |
86 | hsa-miR-21-5p | ASF1A | 2.65 | 0 | -0.07 | 0.84483 | miRNATAP | -0.22 | 0.00016 | NA | |
87 | hsa-miR-106b-5p | ASH1L | 2.81 | 0 | -0.25 | 0.53283 | miRNATAP | -0.1 | 0.03313 | NA | |
88 | hsa-miR-106b-5p | ASPA | 2.81 | 0 | -5.53 | 0 | mirMAP | -0.57 | 7.0E-5 | NA | |
89 | hsa-miR-15b-3p | ASPA | 3.58 | 0 | -5.53 | 0 | mirMAP | -0.58 | 0 | NA | |
90 | hsa-miR-21-5p | ASPN | 2.65 | 0 | -5.37 | 0 | MirTarget; miRNATAP | -0.57 | 0.00092 | NA | |
91 | hsa-miR-21-5p | ASRGL1 | 2.65 | 0 | -0.33 | 0.80276 | miRNAWalker2 validate | -0.52 | 0.02009 | NA | |
92 | hsa-miR-15b-5p | ASTN1 | 3.32 | 0 | -4.82 | 0.0004 | MirTarget | -0.66 | 4.0E-5 | NA | |
93 | hsa-miR-106b-5p | ATP1A2 | 2.81 | 0 | -6.92 | 0 | MirTarget; miRNATAP | -0.8 | 0 | NA | |
94 | hsa-miR-21-5p | ATP2B2 | 2.65 | 0 | -4.37 | 0.00042 | mirMAP | -0.86 | 4.0E-5 | NA | |
95 | hsa-miR-21-5p | ATP2B4 | 2.65 | 0 | -2.13 | 0 | miRNAWalker2 validate; MirTarget | -0.25 | 0.00147 | NA | |
96 | hsa-miR-15b-3p | ATP9A | 3.58 | 0 | -0.07 | 0.89862 | mirMAP | -0.12 | 0.0277 | NA | |
97 | hsa-miR-21-3p | ATRNL1 | 3.5 | 0 | -7.16 | 0 | MirTarget | -0.94 | 0 | NA | |
98 | hsa-miR-21-5p | ATRNL1 | 2.65 | 0 | -7.16 | 0 | MirTarget | -1.25 | 0 | NA | |
99 | hsa-miR-15b-3p | ATXN1 | 3.58 | 0 | -1.43 | 0.00387 | mirMAP; miRNATAP | -0.18 | 0.00035 | NA | |
100 | hsa-miR-21-5p | ATXN10 | 2.65 | 0 | -0.37 | 0.19837 | MirTarget; miRNATAP | -0.14 | 0.00366 | NA | |
101 | hsa-miR-15b-5p | AXIN2 | 3.32 | 0 | -3.82 | 0.00033 | miRTarBase; MirTarget; miRNATAP | -0.47 | 0.00022 | NA | |
102 | hsa-miR-21-5p | B3GALNT1 | 2.65 | 0 | -0.84 | 0.15777 | miRNAWalker2 validate | -0.29 | 0.00347 | NA | |
103 | hsa-miR-15b-5p | BACE1 | 3.32 | 0 | -1.41 | 0.00094 | miRNATAP | -0.19 | 0.00021 | NA | |
104 | hsa-miR-21-3p | BACE1 | 3.5 | 0 | -1.41 | 0.00094 | mirMAP | -0.11 | 0.01137 | NA | |
105 | hsa-miR-21-5p | BACE1 | 2.65 | 0 | -1.41 | 0.00094 | mirMAP | -0.17 | 0.01803 | NA | |
106 | hsa-miR-106b-5p | BACH1 | 2.81 | 0 | 0.1 | 0.82342 | mirMAP | -0.17 | 0.00135 | NA | |
107 | hsa-miR-21-5p | BAHD1 | 2.65 | 0 | -0.56 | 0.08701 | miRNATAP | -0.12 | 0.02198 | NA | |
108 | hsa-miR-106b-5p | BCAS1 | 2.81 | 0 | -0.07 | 0.96835 | mirMAP | -0.48 | 0.0168 | NA | |
109 | hsa-miR-15b-3p | BCL2 | 3.58 | 0 | -3.06 | 1.0E-5 | mirMAP | -0.16 | 0.0243 | 25594541; 26915294; 26884837; 18449891 | MicroRNAs miRNAs encoded by the miR-15 cluster are known to induce G1 arrest and apoptosis by targeting G1 checkpoints and the anti-apoptotic B cell lymphoma 2 BCL-2 gene;As a result transcript levels of the tumor-suppressive miR-15 and let-7 families increased which targeted and decreased the expression of the crucial prosurvival genes BCL-2 and BCL-XL respectively;MiR 15b mediates liver cancer cells proliferation through targeting BCL 2; MiR-15b overexpression downregulated BCL2 mRNA and protein expression obviously P < 0.05; On the contrary miR-15b inhibitor transfection markedly reduced miR-15b expression in liver cancer cells P < 0.05 promoted tumor cell proliferation and increased BCL2 mRNA and protein expression; MiR-15b can inhibit HepG2 cell proliferation and down-regulate BCL2 mRNA and protein expression;miR 15b and miR 16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells; The downregulation of miR-15b and miR-16 in SGC7901/VCR cells was concurrent with the upregulation of Bcl-2 protein; Taken together our findings suggest that miR-15b and miR-16 could play a role in the development of MDR in gastric cancer cells at least in part by modulation of apoptosis via targeting BCL2 |
110 | hsa-miR-15b-5p | BCL2 | 3.32 | 0 | -3.06 | 1.0E-5 | miRNAWalker2 validate; miRTarBase | -0.18 | 0.02793 | 25594541; 26915294; 26884837; 18449891 | MicroRNAs miRNAs encoded by the miR-15 cluster are known to induce G1 arrest and apoptosis by targeting G1 checkpoints and the anti-apoptotic B cell lymphoma 2 BCL-2 gene;As a result transcript levels of the tumor-suppressive miR-15 and let-7 families increased which targeted and decreased the expression of the crucial prosurvival genes BCL-2 and BCL-XL respectively;MiR 15b mediates liver cancer cells proliferation through targeting BCL 2; MiR-15b overexpression downregulated BCL2 mRNA and protein expression obviously P < 0.05; On the contrary miR-15b inhibitor transfection markedly reduced miR-15b expression in liver cancer cells P < 0.05 promoted tumor cell proliferation and increased BCL2 mRNA and protein expression; MiR-15b can inhibit HepG2 cell proliferation and down-regulate BCL2 mRNA and protein expression;miR 15b and miR 16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells; The downregulation of miR-15b and miR-16 in SGC7901/VCR cells was concurrent with the upregulation of Bcl-2 protein; Taken together our findings suggest that miR-15b and miR-16 could play a role in the development of MDR in gastric cancer cells at least in part by modulation of apoptosis via targeting BCL2 |
111 | hsa-miR-21-5p | BCL2 | 2.65 | 0 | -3.06 | 1.0E-5 | miRNAWalker2 validate; miRTarBase | -0.48 | 4.0E-5 | 21468550; 25994220; 25381586; 26555418; 23359184; 22964582; 21376256 | BCL-2 up-regulation could be achieved by miR-21 overexpression which prevented T24 cells from apoptosis induced by doxorubicin; Furthermore the miR-21 induced BCL-2 up-regulation could be cancelled by the PI3K inhibitor LY294002;Meanwhile miR-21 loss reduced STAT3 and Bcl-2 activation causing an increase in the apoptosis of tumour cells in CAC mice;Changes in the sensitivity of osteosarcoma cells to CDDP were examined after transfection with miR-21 mimics or anti-miR-21 or bcl-2 siRNA in combination with CDDP;The expression of Bax Bcl-2 and miR-21 in parental and paclitaxel-resistant cells was detected by RT-PCR and Western blotting;Resveratrol induces apoptosis of pancreatic cancers cells by inhibiting miR 21 regulation of BCL 2 expression; We also used Western blot to measure BCL-2 protein levels after down-regulation of miR-21 expression; Besides down-regulation of miR-21 expression can inhibit BCL-2 expression in PANC-1 CFPAC-1 and MIA Paca-2 cells; Over-expression of miR-21 expression can reverse down-regulation of BCL-2 expression and apoptosis induced by resveratrol; In this study we demonstrated that the effect of resveratrol on apoptosis is due to inhibiting miR-21 regulation of BCL-2 expression;Tumors harvested from these lungs have elevated levels of oncogenic miRNAs miR-21 and miR-155; are deficient for p53-regulated miRNAs; and have heightened expression of miR-34 target genes such as Met and Bcl-2;Bcl 2 upregulation induced by miR 21 via a direct interaction is associated with apoptosis and chemoresistance in MIA PaCa 2 pancreatic cancer cells; However the roles and mechanisms of miRNA miR-21 in regulation of Bcl-2 in pancreatic cancer remain to be elucidated; Then luciferase activity was observed after miR-21 mimics and pRL-TK plasmids containing wild-type and mutant 3'UTRs of Bcl-2 mRNA were co-transfected; Cells transfected with miR-21 inhibitor revealed an opposite trend. There was a significant increase in luciferase activity in the cells transfected with the wild-type pRL-TK plasmid in contrast to those transfected with the mutant one indicating that miR-21 promotes Bcl-2 expression by binding directly to the 3'UTR of Bcl-2 mRNA; Upregulation of Bcl-2 directly induced by miR-21 is associated with apoptosis chemoresistance and proliferation of MIA PaCa-2 pancreatic cancer cells |
112 | hsa-miR-106b-5p | BCL9L | 2.81 | 0 | -0.12 | 0.78985 | mirMAP | -0.17 | 0.00113 | NA | |
113 | hsa-miR-21-5p | BDH2 | 2.65 | 0 | -1.21 | 0.0077 | miRNAWalker2 validate | -0.16 | 0.03547 | NA | |
114 | hsa-miR-15b-5p | BET1L | 3.32 | 0 | -0.9 | 0.00127 | mirMAP | -0.12 | 0.00041 | NA | |
115 | hsa-miR-15b-5p | BEX1 | 3.32 | 0 | -6.13 | 1.0E-5 | miRNAWalker2 validate | -0.54 | 0.00098 | NA | |
116 | hsa-miR-106b-5p | BHLHE41 | 2.81 | 0 | -1.22 | 0.21729 | miRNATAP | -0.45 | 0.00016 | NA | |
117 | hsa-miR-106b-5p | BICD2 | 2.81 | 0 | 0.86 | 0.21413 | MirTarget; miRNATAP | -0.18 | 0.03129 | NA | |
118 | hsa-miR-106b-5p | BMPR2 | 2.81 | 0 | -1.13 | 0.00109 | MirTarget; miRNATAP | -0.12 | 0.00443 | NA | |
119 | hsa-miR-21-5p | BMPR2 | 2.65 | 0 | -1.13 | 0.00109 | miRNAWalker2 validate; miRTarBase; MirTarget | -0.12 | 0.03687 | NA | |
120 | hsa-miR-15b-5p | BMX | 3.32 | 0 | -5.34 | 0 | MirTarget; miRNATAP | -0.66 | 0 | NA | |
121 | hsa-miR-106b-5p | BNC2 | 2.81 | 0 | -6.04 | 0 | miRNATAP | -0.69 | 0 | NA | |
122 | hsa-miR-21-5p | BNC2 | 2.65 | 0 | -6.04 | 0 | miRNATAP | -0.57 | 0.00042 | NA | |
123 | hsa-miR-106b-5p | BNIP3L | 2.81 | 0 | -0.64 | 0.09912 | MirTarget | -0.1 | 0.02447 | NA | |
124 | hsa-miR-21-5p | BOC | 2.65 | 0 | -4.15 | 6.0E-5 | miRNAWalker2 validate | -0.6 | 0.00069 | NA | |
125 | hsa-miR-15b-5p | BTBD19 | 3.32 | 0 | -2.25 | 0.01557 | mirMAP | -0.54 | 0 | NA | |
126 | hsa-miR-106b-5p | BTG2 | 2.81 | 0 | -1.97 | 0.00034 | miRNATAP | -0.19 | 0.00464 | NA | |
127 | hsa-miR-21-5p | BTG2 | 2.65 | 0 | -1.97 | 0.00034 | miRNAWalker2 validate; miRTarBase; miRNATAP | -0.26 | 0.00538 | 24821435 | miR 21 regulates N methyl N nitro N' nitrosoguanidine induced gastric tumorigenesis by targeting FASLG and BTG2 |
128 | hsa-miR-15b-5p | BTLA | 3.32 | 0 | 1.19 | 0.19794 | MirTarget; miRNATAP | -0.23 | 0.04035 | NA | |
129 | hsa-miR-106b-5p | BTN3A3 | 2.81 | 0 | -0.66 | 0.3546 | miRNAWalker2 validate | -0.2 | 0.01786 | NA | |
130 | hsa-miR-15b-5p | BTRC | 3.32 | 0 | -0.39 | 0.22952 | MirTarget; miRNATAP | -0.14 | 0.00015 | NA | |
131 | hsa-miR-21-5p | C11orf87 | 2.65 | 0 | -3.96 | 0.00131 | mirMAP; miRNATAP | -0.57 | 0.00647 | NA | |
132 | hsa-miR-106b-5p | C14orf28 | 2.81 | 0 | -2.36 | 0 | miRNATAP | -0.24 | 0 | NA | |
133 | hsa-miR-15b-5p | C1orf21 | 3.32 | 0 | -1.27 | 0.0681 | mirMAP; miRNATAP | -0.17 | 0.03459 | NA | |
134 | hsa-miR-21-3p | C22orf29 | 3.5 | 0 | 0.56 | 0.12643 | mirMAP | -0.11 | 0.00153 | NA | |
135 | hsa-miR-106b-5p | C3orf70 | 2.81 | 0 | -3.41 | 0.0008 | miRNATAP | -0.44 | 0.00035 | NA | |
136 | hsa-miR-15b-5p | C8orf58 | 3.32 | 0 | -0.83 | 0.04874 | miRNATAP | -0.11 | 0.02179 | NA | |
137 | hsa-miR-15b-3p | CA10 | 3.58 | 0 | -3.41 | 0.01589 | MirTarget | -0.4 | 0.00555 | NA | |
138 | hsa-miR-15b-3p | CA5B | 3.58 | 0 | -1.38 | 0.00093 | mirMAP | -0.11 | 0.01241 | NA | |
139 | hsa-miR-21-3p | CACNA2D1 | 3.5 | 0 | -0.9 | 0.61165 | mirMAP | -0.51 | 0.00299 | NA | |
140 | hsa-miR-15b-3p | CACNB4 | 3.58 | 0 | -1.43 | 0.13647 | mirMAP | -0.21 | 0.033 | NA | |
141 | hsa-miR-15b-5p | CADM1 | 3.32 | 0 | -1.82 | 0.10396 | miRNATAP | -0.3 | 0.02256 | NA | |
142 | hsa-miR-15b-3p | CALCRL | 3.58 | 0 | -3.18 | 3.0E-5 | mirMAP | -0.38 | 0 | NA | |
143 | hsa-miR-106b-5p | CALD1 | 2.81 | 0 | -3.83 | 0 | miRNATAP | -0.43 | 0 | NA | |
144 | hsa-miR-15b-3p | CALN1 | 3.58 | 0 | -3 | 0.04497 | mirMAP | -0.62 | 4.0E-5 | NA | |
145 | hsa-miR-15b-5p | CALN1 | 3.32 | 0 | -3 | 0.04497 | mirMAP | -0.55 | 0.00179 | NA | |
146 | hsa-miR-15b-3p | CAMK2A | 3.58 | 0 | -4.61 | 0.0001 | mirMAP | -0.37 | 0.0021 | NA | |
147 | hsa-miR-106b-5p | CAMK2N1 | 2.81 | 0 | -1.94 | 0.07697 | miRNATAP | -0.32 | 0.0156 | NA | |
148 | hsa-miR-106b-5p | CAMK4 | 2.81 | 0 | 0.83 | 0.3952 | mirMAP | -0.25 | 0.03668 | NA | |
149 | hsa-miR-21-3p | CAMLG | 3.5 | 0 | -1.58 | 0 | MirTarget | -0.11 | 0.00029 | NA | |
150 | hsa-miR-106b-5p | CAPN5 | 2.81 | 0 | -1.42 | 0.21891 | mirMAP | -0.32 | 0.02438 | NA |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|
1 | CARDIOVASCULAR SYSTEM DEVELOPMENT | 117 | 788 | 1.682e-26 | 3.914e-23 |
2 | CIRCULATORY SYSTEM DEVELOPMENT | 117 | 788 | 1.682e-26 | 3.914e-23 |
3 | TISSUE DEVELOPMENT | 169 | 1518 | 2.084e-23 | 3.232e-20 |
4 | REGULATION OF CELL DIFFERENTIATION | 163 | 1492 | 1.058e-21 | 1.231e-18 |
5 | REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT | 175 | 1672 | 2.671e-21 | 2.485e-18 |
6 | CELL DEVELOPMENT | 155 | 1426 | 2.092e-20 | 1.622e-17 |
7 | VASCULATURE DEVELOPMENT | 77 | 469 | 2.664e-20 | 1.771e-17 |
8 | POSITIVE REGULATION OF DEVELOPMENTAL PROCESS | 132 | 1142 | 1.194e-19 | 6.943e-17 |
9 | NEUROGENESIS | 150 | 1402 | 4.229e-19 | 2.186e-16 |
10 | INTRACELLULAR SIGNAL TRANSDUCTION | 162 | 1572 | 5.06e-19 | 2.354e-16 |
11 | BLOOD VESSEL MORPHOGENESIS | 61 | 364 | 9.527e-17 | 4.03e-14 |
12 | NEURON DIFFERENTIATION | 104 | 874 | 1.852e-16 | 7.182e-14 |
13 | CELLULAR RESPONSE TO ENDOGENOUS STIMULUS | 114 | 1008 | 2.47e-16 | 8.84e-14 |
14 | RESPONSE TO ENDOGENOUS STIMULUS | 146 | 1450 | 2.857e-16 | 9.495e-14 |
15 | ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY | 88 | 689 | 6.803e-16 | 1.978e-13 |
16 | HEART DEVELOPMENT | 69 | 466 | 6.732e-16 | 1.978e-13 |
17 | REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS | 113 | 1021 | 1.598e-15 | 4.374e-13 |
18 | REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION | 158 | 1656 | 1.779e-15 | 4.598e-13 |
19 | REGULATION OF PHOSPHORUS METABOLIC PROCESS | 155 | 1618 | 2.448e-15 | 5.994e-13 |
20 | REGULATION OF PROTEIN MODIFICATION PROCESS | 161 | 1710 | 2.979e-15 | 6.931e-13 |
21 | REGULATION OF CELL DEVELOPMENT | 98 | 836 | 3.891e-15 | 8.621e-13 |
22 | ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS | 107 | 957 | 4.905e-15 | 1.038e-12 |
23 | REGULATION OF CELLULAR COMPONENT MOVEMENT | 92 | 771 | 9.869e-15 | 1.997e-12 |
24 | POSITIVE REGULATION OF CELL DIFFERENTIATION | 96 | 823 | 1.037e-14 | 2.01e-12 |
25 | ORGAN MORPHOGENESIS | 97 | 841 | 1.513e-14 | 2.816e-12 |
26 | MUSCLE STRUCTURE DEVELOPMENT | 63 | 432 | 2.637e-14 | 4.719e-12 |
27 | CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION | 70 | 513 | 2.792e-14 | 4.812e-12 |
28 | EPITHELIUM DEVELOPMENT | 104 | 945 | 3.457e-14 | 5.744e-12 |
29 | REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER | 162 | 1784 | 5.728e-14 | 9.19e-12 |
30 | POSITIVE REGULATION OF CELL COMMUNICATION | 145 | 1532 | 6.058e-14 | 9.276e-12 |
31 | CELLULAR COMPONENT MORPHOGENESIS | 100 | 900 | 6.18e-14 | 9.276e-12 |
32 | POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS | 135 | 1395 | 9.719e-14 | 1.413e-11 |
33 | TUBE DEVELOPMENT | 72 | 552 | 1.18e-13 | 1.664e-11 |
34 | REGULATION OF NEURON DIFFERENTIATION | 72 | 554 | 1.416e-13 | 1.937e-11 |
35 | NEURON PROJECTION DEVELOPMENT | 71 | 545 | 1.87e-13 | 2.487e-11 |
36 | REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS | 42 | 229 | 2.774e-13 | 3.412e-11 |
37 | POSITIVE REGULATION OF LOCOMOTION | 60 | 420 | 2.773e-13 | 3.412e-11 |
38 | CELLULAR RESPONSE TO ORGANIC SUBSTANCE | 164 | 1848 | 2.786e-13 | 3.412e-11 |
39 | BIOLOGICAL ADHESION | 108 | 1032 | 2.939e-13 | 3.507e-11 |
40 | POSITIVE REGULATION OF GENE EXPRESSION | 156 | 1733 | 3.783e-13 | 4.4e-11 |
41 | ANGIOGENESIS | 48 | 293 | 4.524e-13 | 5.134e-11 |
42 | TISSUE MORPHOGENESIS | 69 | 533 | 5.622e-13 | 6.228e-11 |
43 | TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY | 66 | 498 | 6.174e-13 | 6.681e-11 |
44 | MUSCLE TISSUE DEVELOPMENT | 46 | 275 | 6.499e-13 | 6.873e-11 |
45 | REGULATION OF NERVOUS SYSTEM DEVELOPMENT | 86 | 750 | 7.232e-13 | 7.478e-11 |
46 | POSITIVE REGULATION OF PHOSPHATE METABOLIC PROCESS | 107 | 1036 | 8.855e-13 | 8.767e-11 |
47 | POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS | 107 | 1036 | 8.855e-13 | 8.767e-11 |
48 | RESPONSE TO GROWTH FACTOR | 63 | 475 | 2.034e-12 | 1.972e-10 |
49 | POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS | 113 | 1135 | 2.117e-12 | 2.01e-10 |
50 | REGULATION OF CHEMOTAXIS | 35 | 180 | 4.743e-12 | 4.414e-10 |
51 | CENTRAL NERVOUS SYSTEM DEVELOPMENT | 93 | 872 | 5.252e-12 | 4.792e-10 |
52 | PROTEIN PHOSPHORYLATION | 98 | 944 | 6.538e-12 | 5.851e-10 |
53 | REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION | 50 | 337 | 6.762e-12 | 5.936e-10 |
54 | POSITIVE REGULATION OF RESPONSE TO STIMULUS | 164 | 1929 | 9.605e-12 | 8.277e-10 |
55 | MORPHOGENESIS OF A BRANCHING STRUCTURE | 33 | 167 | 1.221e-11 | 1.033e-09 |
56 | MUSCLE ORGAN DEVELOPMENT | 44 | 277 | 1.252e-11 | 1.04e-09 |
57 | NEURON DEVELOPMENT | 78 | 687 | 1.473e-11 | 1.202e-09 |
58 | POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION | 92 | 876 | 1.615e-11 | 1.295e-09 |
59 | POSITIVE REGULATION OF MOLECULAR FUNCTION | 154 | 1791 | 2e-11 | 1.578e-09 |
60 | REGULATION OF NEURON PROJECTION DEVELOPMENT | 55 | 408 | 2.815e-11 | 2.183e-09 |
61 | REGULATION OF CELL PROLIFERATION | 134 | 1496 | 3.224e-11 | 2.459e-09 |
62 | MOVEMENT OF CELL OR SUBCELLULAR COMPONENT | 119 | 1275 | 3.644e-11 | 2.735e-09 |
63 | CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND | 85 | 799 | 5.227e-11 | 3.86e-09 |
64 | REGULATION OF CELL MORPHOGENESIS | 66 | 552 | 6.377e-11 | 4.636e-09 |
65 | POSITIVE REGULATION OF CATALYTIC ACTIVITY | 134 | 1518 | 8.751e-11 | 6.265e-09 |
66 | REGULATION OF MAPK CASCADE | 74 | 660 | 9.035e-11 | 6.37e-09 |
67 | POSITIVE REGULATION OF BIOSYNTHETIC PROCESS | 152 | 1805 | 1.299e-10 | 9.019e-09 |
68 | POSITIVE REGULATION OF CELL PROLIFERATION | 85 | 814 | 1.345e-10 | 9.201e-09 |
69 | REGULATION OF MEMBRANE POTENTIAL | 48 | 343 | 1.431e-10 | 9.652e-09 |
70 | ACTIN FILAMENT BASED PROCESS | 57 | 450 | 1.455e-10 | 9.671e-09 |
71 | NEURON PROJECTION MORPHOGENESIS | 53 | 402 | 1.493e-10 | 9.783e-09 |
72 | REGULATION OF KINASE ACTIVITY | 82 | 776 | 1.626e-10 | 1.051e-08 |
73 | PEPTIDYL TYROSINE MODIFICATION | 33 | 186 | 2.458e-10 | 1.567e-08 |
74 | POSITIVE REGULATION OF CELL DEVELOPMENT | 58 | 472 | 3.295e-10 | 2.072e-08 |
75 | POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS | 130 | 1492 | 4.078e-10 | 2.53e-08 |
76 | POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER | 97 | 1004 | 4.564e-10 | 2.794e-08 |
77 | REGULATION OF GTPASE ACTIVITY | 73 | 673 | 5.439e-10 | 3.287e-08 |
78 | TUBE MORPHOGENESIS | 45 | 323 | 6.251e-10 | 3.729e-08 |
79 | CELL PROJECTION ORGANIZATION | 89 | 902 | 8.86e-10 | 5.218e-08 |
80 | MORPHOGENESIS OF AN EPITHELIUM | 51 | 400 | 1.091e-09 | 6.343e-08 |
81 | CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION | 48 | 368 | 1.589e-09 | 9.125e-08 |
82 | DEVELOPMENTAL GROWTH | 45 | 333 | 1.677e-09 | 9.519e-08 |
83 | NEGATIVE REGULATION OF RESPONSE TO STIMULUS | 119 | 1360 | 1.932e-09 | 1.083e-07 |
84 | POSITIVE REGULATION OF MAPK CASCADE | 56 | 470 | 2.102e-09 | 1.164e-07 |
85 | GROWTH | 51 | 410 | 2.572e-09 | 1.408e-07 |
86 | NEGATIVE REGULATION OF CELL COMMUNICATION | 107 | 1192 | 3.49e-09 | 1.888e-07 |
87 | REGULATION OF TRANSFERASE ACTIVITY | 90 | 946 | 4.334e-09 | 2.318e-07 |
88 | REGULATION OF CELL PROJECTION ORGANIZATION | 62 | 558 | 4.514e-09 | 2.36e-07 |
89 | ORGAN GROWTH | 18 | 68 | 4.48e-09 | 2.36e-07 |
90 | PHOSPHORYLATION | 109 | 1228 | 4.567e-09 | 2.361e-07 |
91 | SKELETAL SYSTEM DEVELOPMENT | 54 | 455 | 4.7e-09 | 2.403e-07 |
92 | POSITIVE REGULATION OF KINASE ACTIVITY | 56 | 482 | 5.258e-09 | 2.659e-07 |
93 | CARDIAC MUSCLE TISSUE DEVELOPMENT | 26 | 140 | 7.226e-09 | 3.616e-07 |
94 | HEART MORPHOGENESIS | 33 | 212 | 7.72e-09 | 3.821e-07 |
95 | BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE | 25 | 131 | 7.877e-09 | 3.858e-07 |
96 | POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT | 52 | 437 | 8.315e-09 | 4.03e-07 |
97 | NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS | 79 | 801 | 8.419e-09 | 4.038e-07 |
98 | NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS | 60 | 541 | 8.625e-09 | 4.054e-07 |
99 | NEGATIVE REGULATION OF PHOSPHATE METABOLIC PROCESS | 60 | 541 | 8.625e-09 | 4.054e-07 |
100 | CELL CELL ADHESION | 65 | 608 | 8.776e-09 | 4.083e-07 |
101 | NEGATIVE REGULATION OF CELL DIFFERENTIATION | 65 | 609 | 9.359e-09 | 4.311e-07 |
102 | HEAD DEVELOPMENT | 72 | 709 | 1.198e-08 | 5.467e-07 |
103 | REGULATION OF SYSTEM PROCESS | 57 | 507 | 1.26e-08 | 5.69e-07 |
104 | MESENCHYMAL CELL DIFFERENTIATION | 25 | 134 | 1.273e-08 | 5.694e-07 |
105 | CARDIAC CHAMBER DEVELOPMENT | 26 | 144 | 1.333e-08 | 5.908e-07 |
106 | KIDNEY EPITHELIUM DEVELOPMENT | 24 | 125 | 1.381e-08 | 6.063e-07 |
107 | REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY | 54 | 470 | 1.456e-08 | 6.333e-07 |
108 | UROGENITAL SYSTEM DEVELOPMENT | 40 | 299 | 1.795e-08 | 7.731e-07 |
109 | RESPONSE TO OXYGEN LEVELS | 41 | 311 | 1.821e-08 | 7.772e-07 |
110 | NEGATIVE REGULATION OF PHOSPHORYLATION | 50 | 422 | 1.855e-08 | 7.848e-07 |
111 | REGULATION OF HYDROLASE ACTIVITY | 113 | 1327 | 2.314e-08 | 9.699e-07 |
112 | APPENDAGE DEVELOPMENT | 28 | 169 | 2.639e-08 | 1.077e-06 |
113 | LIMB DEVELOPMENT | 28 | 169 | 2.639e-08 | 1.077e-06 |
114 | STEM CELL DIFFERENTIATION | 30 | 190 | 2.639e-08 | 1.077e-06 |
115 | NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER | 73 | 740 | 3.146e-08 | 1.273e-06 |
116 | NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS | 23 | 121 | 3.356e-08 | 1.346e-06 |
117 | POSITIVE REGULATION OF NEURON DIFFERENTIATION | 40 | 306 | 3.441e-08 | 1.368e-06 |
118 | POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION | 21 | 103 | 3.688e-08 | 1.454e-06 |
119 | LOCOMOTION | 98 | 1114 | 4.559e-08 | 1.783e-06 |
120 | EMBRYO DEVELOPMENT | 83 | 894 | 5.304e-08 | 2.057e-06 |
121 | RESPONSE TO TRANSFORMING GROWTH FACTOR BETA | 25 | 144 | 5.665e-08 | 2.178e-06 |
122 | POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION | 100 | 1152 | 6.339e-08 | 2.418e-06 |
123 | REGULATION OF TRANSPORTER ACTIVITY | 30 | 198 | 6.842e-08 | 2.588e-06 |
124 | NEGATIVE REGULATION OF CELL DEATH | 81 | 872 | 7.568e-08 | 2.84e-06 |
125 | MESENCHYME DEVELOPMENT | 29 | 190 | 9.585e-08 | 3.568e-06 |
126 | EMBRYONIC MORPHOGENESIS | 57 | 539 | 1.064e-07 | 3.93e-06 |
127 | PHOSPHATE CONTAINING COMPOUND METABOLIC PROCESS | 151 | 1977 | 1.096e-07 | 4.015e-06 |
128 | MUSCLE CELL DIFFERENTIATION | 33 | 237 | 1.216e-07 | 4.422e-06 |
129 | POSITIVE REGULATION OF CHEMOTAXIS | 22 | 120 | 1.3e-07 | 4.688e-06 |
130 | CONNECTIVE TISSUE DEVELOPMENT | 29 | 194 | 1.518e-07 | 5.432e-06 |
131 | CELLULAR RESPONSE TO NITROGEN COMPOUND | 54 | 505 | 1.612e-07 | 5.726e-06 |
132 | REGULATION OF CELL DEATH | 119 | 1472 | 1.642e-07 | 5.788e-06 |
133 | CELL PROLIFERATION | 66 | 672 | 1.727e-07 | 6.016e-06 |
134 | POSITIVE REGULATION OF TRANSFERASE ACTIVITY | 62 | 616 | 1.745e-07 | 6.016e-06 |
135 | NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS | 62 | 616 | 1.745e-07 | 6.016e-06 |
136 | PALATE DEVELOPMENT | 18 | 85 | 1.883e-07 | 6.367e-06 |
137 | REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY | 30 | 207 | 1.867e-07 | 6.367e-06 |
138 | RESPONSE TO OXYGEN CONTAINING COMPOUND | 113 | 1381 | 1.888e-07 | 6.367e-06 |
139 | RESPONSE TO HORMONE | 81 | 893 | 2.06e-07 | 6.897e-06 |
140 | REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION | 36 | 278 | 2.094e-07 | 6.933e-06 |
141 | SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION | 42 | 352 | 2.101e-07 | 6.933e-06 |
142 | REGULATION OF BMP SIGNALING PATHWAY | 17 | 77 | 2.171e-07 | 7.115e-06 |
143 | INOSITOL LIPID MEDIATED SIGNALING | 22 | 124 | 2.367e-07 | 7.703e-06 |
144 | BONE DEVELOPMENT | 25 | 156 | 2.813e-07 | 9.088e-06 |
145 | REGULATION OF OSSIFICATION | 27 | 178 | 2.993e-07 | 9.606e-06 |
146 | REGULATION OF MAP KINASE ACTIVITY | 39 | 319 | 3.029e-07 | 9.654e-06 |
147 | FOREBRAIN DEVELOPMENT | 42 | 357 | 3.093e-07 | 9.789e-06 |
148 | REGULATION OF WNT SIGNALING PATHWAY | 38 | 310 | 4.008e-07 | 1.26e-05 |
149 | REGIONALIZATION | 38 | 311 | 4.35e-07 | 1.358e-05 |
150 | CELL PART MORPHOGENESIS | 62 | 633 | 4.51e-07 | 1.399e-05 |
151 | EPITHELIAL CELL DIFFERENTIATION | 52 | 495 | 4.743e-07 | 1.461e-05 |
152 | REGULATION OF DEVELOPMENTAL GROWTH | 36 | 289 | 5.455e-07 | 1.67e-05 |
153 | CIRCULATORY SYSTEM PROCESS | 42 | 366 | 6.06e-07 | 1.843e-05 |
154 | PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS | 13 | 49 | 6.119e-07 | 1.849e-05 |
155 | POSITIVE REGULATION OF WNT SIGNALING PATHWAY | 24 | 152 | 6.4e-07 | 1.921e-05 |
156 | POSITIVE REGULATION OF HYDROLASE ACTIVITY | 80 | 905 | 6.957e-07 | 2.075e-05 |
157 | NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY | 19 | 102 | 7.155e-07 | 2.121e-05 |
158 | HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES | 24 | 153 | 7.234e-07 | 2.13e-05 |
159 | POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT | 31 | 232 | 7.29e-07 | 2.133e-05 |
160 | LIPID MODIFICATION | 29 | 210 | 8.313e-07 | 2.418e-05 |
161 | REGULATION OF SYNAPSE ORGANIZATION | 20 | 113 | 8.616e-07 | 2.49e-05 |
162 | POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION | 15 | 67 | 9.222e-07 | 2.649e-05 |
163 | REGULATION OF EPITHELIAL CELL MIGRATION | 25 | 166 | 9.342e-07 | 2.667e-05 |
164 | CARDIAC SEPTUM DEVELOPMENT | 17 | 85 | 9.658e-07 | 2.735e-05 |
165 | CARDIAC CHAMBER MORPHOGENESIS | 19 | 104 | 9.756e-07 | 2.735e-05 |
166 | DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS | 19 | 104 | 9.756e-07 | 2.735e-05 |
167 | CYTOSKELETON ORGANIZATION | 75 | 838 | 9.859e-07 | 2.747e-05 |
168 | SKELETAL SYSTEM MORPHOGENESIS | 28 | 201 | 1.072e-06 | 2.969e-05 |
169 | PEPTIDYL AMINO ACID MODIFICATION | 75 | 841 | 1.128e-06 | 3.106e-05 |
170 | NEPHRON DEVELOPMENT | 20 | 115 | 1.149e-06 | 3.146e-05 |
171 | REGULATION OF CELL CYCLE | 82 | 949 | 1.254e-06 | 3.413e-05 |
172 | REGULATION OF ACTIN FILAMENT BASED PROCESS | 37 | 312 | 1.277e-06 | 3.454e-05 |
173 | IMMUNE SYSTEM DEVELOPMENT | 57 | 582 | 1.32e-06 | 3.53e-05 |
174 | CARDIAC VENTRICLE DEVELOPMENT | 19 | 106 | 1.319e-06 | 3.53e-05 |
175 | EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING | 55 | 554 | 1.334e-06 | 3.546e-05 |
176 | PROTEIN AUTOPHOSPHORYLATION | 27 | 192 | 1.379e-06 | 3.646e-05 |
177 | RENAL TUBULE DEVELOPMENT | 16 | 78 | 1.406e-06 | 3.697e-05 |
178 | PATTERN SPECIFICATION PROCESS | 45 | 418 | 1.44e-06 | 3.743e-05 |
179 | NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION | 64 | 684 | 1.435e-06 | 3.743e-05 |
180 | MEMBRANE DEPOLARIZATION | 14 | 61 | 1.543e-06 | 3.988e-05 |
181 | REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING | 22 | 138 | 1.573e-06 | 4.043e-05 |
182 | REGULATION OF CELL ADHESION | 60 | 629 | 1.652e-06 | 4.222e-05 |
183 | CELL MOTILITY | 74 | 835 | 1.68e-06 | 4.23e-05 |
184 | LOCALIZATION OF CELL | 74 | 835 | 1.68e-06 | 4.23e-05 |
185 | BONE MORPHOGENESIS | 16 | 79 | 1.682e-06 | 4.23e-05 |
186 | POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION | 36 | 303 | 1.695e-06 | 4.239e-05 |
187 | REGULATION OF CELL SUBSTRATE ADHESION | 25 | 173 | 2.031e-06 | 5.053e-05 |
188 | MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL | 7 | 14 | 2.046e-06 | 5.064e-05 |
189 | POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION | 24 | 162 | 2.068e-06 | 5.09e-05 |
190 | REGULATION OF CATION TRANSMEMBRANE TRANSPORT | 28 | 208 | 2.138e-06 | 5.235e-05 |
191 | POSITIVE REGULATION OF CELL CYCLE | 38 | 332 | 2.196e-06 | 5.349e-05 |
192 | REGULATION OF DENDRITE DEVELOPMENT | 20 | 120 | 2.291e-06 | 5.551e-05 |
193 | REGULATION OF AXON GUIDANCE | 11 | 39 | 2.323e-06 | 5.599e-05 |
194 | MUSCLE SYSTEM PROCESS | 34 | 282 | 2.353e-06 | 5.644e-05 |
195 | RESPONSE TO NITROGEN COMPOUND | 75 | 859 | 2.477e-06 | 5.912e-05 |
196 | REGULATION OF CELL DIVISION | 33 | 272 | 2.877e-06 | 6.83e-05 |
197 | NEGATIVE REGULATION OF GENE EXPRESSION | 115 | 1493 | 2.941e-06 | 6.946e-05 |
198 | MAMMARY GLAND MORPHOGENESIS | 11 | 40 | 3.058e-06 | 7.158e-05 |
199 | RHYTHMIC PROCESS | 35 | 298 | 3.062e-06 | 7.158e-05 |
200 | POSITIVE REGULATION OF VASCULATURE DEVELOPMENT | 21 | 133 | 3.162e-06 | 7.357e-05 |
201 | CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION | 24 | 166 | 3.205e-06 | 7.42e-05 |
202 | SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION | 43 | 404 | 3.3e-06 | 7.602e-05 |
203 | REGULATION OF METAL ION TRANSPORT | 37 | 325 | 3.377e-06 | 7.739e-05 |
204 | NEPHRON EPITHELIUM DEVELOPMENT | 17 | 93 | 3.566e-06 | 8.134e-05 |
205 | BEHAVIOR | 51 | 516 | 3.665e-06 | 8.32e-05 |
206 | NEGATIVE REGULATION OF NITROGEN COMPOUND METABOLIC PROCESS | 116 | 1517 | 3.748e-06 | 8.467e-05 |
207 | RESPONSE TO ABIOTIC STIMULUS | 85 | 1024 | 3.959e-06 | 8.874e-05 |
208 | REGULATION OF AXONOGENESIS | 24 | 168 | 3.967e-06 | 8.874e-05 |
209 | NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS | 89 | 1087 | 4.043e-06 | 9.001e-05 |
210 | REGULATION OF GROWTH | 59 | 633 | 4.179e-06 | 9.258e-05 |
211 | PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 10 | 34 | 4.419e-06 | 9.699e-05 |
212 | POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION | 10 | 34 | 4.419e-06 | 9.699e-05 |
213 | CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES | 27 | 204 | 4.471e-06 | 9.767e-05 |
214 | CARTILAGE DEVELOPMENT | 22 | 147 | 4.596e-06 | 9.991e-05 |
215 | HEART PROCESS | 16 | 85 | 4.617e-06 | 9.991e-05 |
216 | EXTRACELLULAR STRUCTURE ORGANIZATION | 35 | 304 | 4.8e-06 | 0.0001034 |
217 | CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND | 47 | 465 | 4.832e-06 | 0.0001036 |
218 | NEGATIVE REGULATION OF BMP SIGNALING PATHWAY | 11 | 42 | 5.161e-06 | 0.0001102 |
219 | POSITIVE REGULATION OF STEM CELL DIFFERENTIATION | 12 | 50 | 5.217e-06 | 0.0001108 |
220 | CELLULAR RESPONSE TO HORMONE STIMULUS | 53 | 552 | 5.527e-06 | 0.0001169 |
221 | REGULATION OF TRANSMEMBRANE TRANSPORT | 44 | 426 | 5.561e-06 | 0.0001171 |
222 | VASCULOGENESIS | 13 | 59 | 5.899e-06 | 0.0001236 |
223 | POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS | 6 | 11 | 6.031e-06 | 0.0001255 |
224 | REGULATION OF RECEPTOR ACTIVITY | 19 | 117 | 6.042e-06 | 0.0001255 |
225 | REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY | 29 | 232 | 6.313e-06 | 0.0001306 |
226 | MUSCLE CELL DEVELOPMENT | 20 | 128 | 6.347e-06 | 0.0001307 |
227 | GLAND MORPHOGENESIS | 17 | 97 | 6.461e-06 | 0.0001324 |
228 | STRIATED MUSCLE CELL DIFFERENTIATION | 24 | 173 | 6.645e-06 | 0.0001356 |
229 | CELLULAR RESPONSE TO LIPID | 46 | 457 | 6.785e-06 | 0.0001379 |
230 | RESPIRATORY SYSTEM DEVELOPMENT | 26 | 197 | 7.036e-06 | 0.0001423 |
231 | REGULATION OF CALCIUM ION TRANSPORT | 27 | 209 | 7.067e-06 | 0.0001424 |
232 | REGULATION OF ANATOMICAL STRUCTURE SIZE | 47 | 472 | 7.201e-06 | 0.0001444 |
233 | POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT | 9 | 29 | 8.19e-06 | 0.0001636 |
234 | LIPID PHOSPHORYLATION | 17 | 99 | 8.583e-06 | 0.0001707 |
235 | CELLULAR RESPONSE TO PEPTIDE | 32 | 274 | 9.013e-06 | 0.0001785 |
236 | NEURON MIGRATION | 18 | 110 | 9.454e-06 | 0.0001864 |
237 | REGULATION OF ION TRANSPORT | 55 | 592 | 9.699e-06 | 0.0001904 |
238 | NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION | 12 | 53 | 9.969e-06 | 0.0001933 |
239 | REGULATION OF CELL MATRIX ADHESION | 16 | 90 | 9.941e-06 | 0.0001933 |
240 | MESONEPHROS DEVELOPMENT | 16 | 90 | 9.941e-06 | 0.0001933 |
241 | POSITIVE REGULATION OF CELL DIVISION | 20 | 132 | 1.02e-05 | 0.000195 |
242 | MAINTENANCE OF CELL NUMBER | 20 | 132 | 1.02e-05 | 0.000195 |
243 | CARDIAC MUSCLE CELL ACTION POTENTIAL | 10 | 37 | 1.022e-05 | 0.000195 |
244 | REGULATION OF PROTEIN AUTOPHOSPHORYLATION | 10 | 37 | 1.022e-05 | 0.000195 |
245 | NEGATIVE REGULATION OF LOCOMOTION | 31 | 263 | 1.028e-05 | 0.0001952 |
246 | REGULATION OF ERK1 AND ERK2 CASCADE | 29 | 238 | 1.04e-05 | 0.0001967 |
247 | CARDIAC VENTRICLE MORPHOGENESIS | 13 | 62 | 1.052e-05 | 0.0001982 |
248 | VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT | 11 | 45 | 1.065e-05 | 0.000199 |
249 | ENDOCHONDRAL BONE MORPHOGENESIS | 11 | 45 | 1.065e-05 | 0.000199 |
250 | REGULATION OF ORGANELLE ORGANIZATION | 93 | 1178 | 1.071e-05 | 0.0001993 |
251 | COGNITION | 30 | 251 | 1.081e-05 | 0.0002003 |
252 | REGULATION OF DENDRITIC SPINE MORPHOGENESIS | 9 | 30 | 1.118e-05 | 0.0002064 |
253 | PROTEIN LOCALIZATION | 131 | 1805 | 1.182e-05 | 0.0002174 |
254 | SINGLE ORGANISM BEHAVIOR | 40 | 384 | 1.202e-05 | 0.0002202 |
255 | CARDIAC MUSCLE TISSUE MORPHOGENESIS | 12 | 54 | 1.223e-05 | 0.0002224 |
256 | POSITIVE REGULATION OF DEVELOPMENTAL GROWTH | 22 | 156 | 1.22e-05 | 0.0002224 |
257 | SYNAPSE ORGANIZATION | 21 | 145 | 1.263e-05 | 0.0002287 |
258 | MULTICELLULAR ORGANISMAL SIGNALING | 19 | 123 | 1.271e-05 | 0.0002293 |
259 | RESPONSE TO ORGANIC CYCLIC COMPOUND | 76 | 917 | 1.377e-05 | 0.0002474 |
260 | RESPONSE TO ESTRADIOL | 21 | 146 | 1.407e-05 | 0.0002508 |
261 | CELLULAR RESPONSE TO INSULIN STIMULUS | 21 | 146 | 1.407e-05 | 0.0002508 |
262 | DEVELOPMENTAL MATURATION | 25 | 193 | 1.457e-05 | 0.0002587 |
263 | REGULATION OF ENDOTHELIAL CELL MIGRATION | 18 | 114 | 1.57e-05 | 0.0002767 |
264 | NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS | 80 | 983 | 1.569e-05 | 0.0002767 |
265 | RESPONSE TO ALCOHOL | 38 | 362 | 1.658e-05 | 0.0002911 |
266 | ACTIN MEDIATED CELL CONTRACTION | 14 | 74 | 1.695e-05 | 0.0002965 |
267 | MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL | 10 | 39 | 1.702e-05 | 0.0002966 |
268 | ACTION POTENTIAL | 16 | 94 | 1.759e-05 | 0.0003054 |
269 | SKELETAL MUSCLE ORGAN DEVELOPMENT | 20 | 137 | 1.791e-05 | 0.0003099 |
270 | EPITHELIAL TO MESENCHYMAL TRANSITION | 12 | 56 | 1.815e-05 | 0.0003104 |
271 | REGULATION OF DENDRITIC SPINE DEVELOPMENT | 12 | 56 | 1.815e-05 | 0.0003104 |
272 | POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT | 12 | 56 | 1.815e-05 | 0.0003104 |
273 | REGULATION OF RESPONSE TO EXTERNAL STIMULUS | 76 | 926 | 1.928e-05 | 0.0003286 |
274 | EMBRYONIC ORGAN DEVELOPMENT | 41 | 406 | 1.964e-05 | 0.0003335 |
275 | REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT | 18 | 116 | 2.004e-05 | 0.000339 |
276 | GLAND DEVELOPMENT | 40 | 395 | 2.318e-05 | 0.0003909 |
277 | REGULATION OF CATABOLIC PROCESS | 63 | 731 | 2.373e-05 | 0.0003987 |
278 | POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION | 7 | 19 | 2.404e-05 | 0.0004024 |
279 | NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT | 30 | 262 | 2.49e-05 | 0.0004152 |
280 | REGULATION OF SMOOTH MUSCLE CELL MIGRATION | 11 | 49 | 2.54e-05 | 0.0004211 |
281 | REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION | 13 | 67 | 2.543e-05 | 0.0004211 |
282 | NEGATIVE REGULATION OF CELL PROLIFERATION | 57 | 643 | 2.629e-05 | 0.0004337 |
283 | CELL SUBSTRATE ADHESION | 22 | 164 | 2.707e-05 | 0.000445 |
284 | NEGATIVE REGULATION OF CELL DEVELOPMENT | 33 | 303 | 2.804e-05 | 0.0004594 |
285 | REGULATION OF ION HOMEOSTASIS | 25 | 201 | 2.929e-05 | 0.0004783 |
286 | CELLULAR RESPONSE TO OXYGEN LEVELS | 20 | 143 | 3.381e-05 | 0.0005482 |
287 | RAS PROTEIN SIGNAL TRANSDUCTION | 20 | 143 | 3.381e-05 | 0.0005482 |
288 | REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY | 16 | 99 | 3.421e-05 | 0.0005508 |
289 | REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS | 16 | 99 | 3.421e-05 | 0.0005508 |
290 | NEGATIVE REGULATION OF NEURON DIFFERENTIATION | 24 | 191 | 3.552e-05 | 0.00057 |
291 | EPITHELIAL CELL PROLIFERATION | 15 | 89 | 3.603e-05 | 0.0005762 |
292 | DENDRITE DEVELOPMENT | 14 | 79 | 3.658e-05 | 0.0005809 |
293 | REGULATION OF SYNAPSE ASSEMBLY | 14 | 79 | 3.658e-05 | 0.0005809 |
294 | REGULATION OF ORGAN MORPHOGENESIS | 28 | 242 | 3.802e-05 | 0.0006016 |
295 | POSITIVE REGULATION OF HEART GROWTH | 8 | 27 | 3.838e-05 | 0.0006033 |
296 | NEGATIVE REGULATION OF AXON GUIDANCE | 8 | 27 | 3.838e-05 | 0.0006033 |
297 | REGULATION OF HOMEOSTATIC PROCESS | 43 | 447 | 3.988e-05 | 0.0006248 |
298 | NEURON PROJECTION GUIDANCE | 25 | 205 | 4.084e-05 | 0.0006377 |
299 | NEGATIVE REGULATION OF MAPK CASCADE | 20 | 145 | 4.141e-05 | 0.000638 |
300 | MUSCLE ORGAN MORPHOGENESIS | 13 | 70 | 4.135e-05 | 0.000638 |
301 | ENDOTHELIUM DEVELOPMENT | 15 | 90 | 4.125e-05 | 0.000638 |
302 | REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 13 | 70 | 4.135e-05 | 0.000638 |
303 | POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS | 32 | 296 | 4.262e-05 | 0.0006545 |
304 | WNT SIGNALING PATHWAY | 36 | 351 | 4.483e-05 | 0.0006861 |
305 | NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE | 11 | 52 | 4.584e-05 | 0.0006971 |
306 | ANTERIOR POSTERIOR PATTERN SPECIFICATION | 24 | 194 | 4.582e-05 | 0.0006971 |
307 | POSITIVE REGULATION OF MAP KINASE ACTIVITY | 25 | 207 | 4.803e-05 | 0.0007279 |
308 | REGULATION OF EPITHELIAL CELL PROLIFERATION | 31 | 285 | 4.97e-05 | 0.0007508 |
309 | NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION | 42 | 437 | 4.988e-05 | 0.000751 |
310 | REGULATION OF VASCULATURE DEVELOPMENT | 27 | 233 | 5.057e-05 | 0.000758 |
311 | REGULATION OF STEM CELL DIFFERENTIATION | 17 | 113 | 5.066e-05 | 0.000758 |
312 | MAMMARY GLAND DUCT MORPHOGENESIS | 8 | 28 | 5.136e-05 | 0.000766 |
313 | BRANCHING INVOLVED IN URETERIC BUD MORPHOGENESIS | 10 | 44 | 5.281e-05 | 0.000785 |
314 | REGULATION OF SMOOTHENED SIGNALING PATHWAY | 12 | 62 | 5.311e-05 | 0.000787 |
315 | MAMMARY GLAND EPITHELIUM DEVELOPMENT | 11 | 53 | 5.524e-05 | 0.0008134 |
316 | MESONEPHRIC TUBULE MORPHOGENESIS | 11 | 53 | 5.524e-05 | 0.0008134 |
317 | REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION | 23 | 184 | 5.566e-05 | 0.000817 |
318 | DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION | 53 | 602 | 6.003e-05 | 0.0008783 |
319 | ACTIN FILAMENT BASED MOVEMENT | 15 | 93 | 6.111e-05 | 0.0008913 |
320 | REGULATION OF CANONICAL WNT SIGNALING PATHWAY | 27 | 236 | 6.313e-05 | 0.000918 |
321 | POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY | 31 | 289 | 6.467e-05 | 0.0009374 |
322 | VENTRICULAR SEPTUM DEVELOPMENT | 11 | 54 | 6.624e-05 | 0.0009572 |
323 | REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION | 8 | 29 | 6.781e-05 | 0.0009738 |
324 | CARDIAC MUSCLE CELL CONTRACTION | 8 | 29 | 6.781e-05 | 0.0009738 |
325 | RESPONSE TO BMP | 15 | 94 | 6.937e-05 | 0.0009901 |
326 | CELLULAR RESPONSE TO BMP STIMULUS | 15 | 94 | 6.937e-05 | 0.0009901 |
327 | HOMEOSTATIC PROCESS | 99 | 1337 | 7.125e-05 | 0.001014 |
328 | POSITIVE REGULATION OF GROWTH | 27 | 238 | 7.3e-05 | 0.001032 |
329 | OSSIFICATION | 28 | 251 | 7.281e-05 | 0.001032 |
330 | REGULATION OF DENDRITE MORPHOGENESIS | 13 | 74 | 7.565e-05 | 0.001067 |
331 | REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL | 11 | 55 | 7.906e-05 | 0.001108 |
332 | NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION | 17 | 117 | 7.927e-05 | 0.001108 |
333 | MAMMARY GLAND DEVELOPMENT | 17 | 117 | 7.927e-05 | 0.001108 |
334 | REGULATION OF MUSCLE CELL DIFFERENTIATION | 20 | 152 | 8.139e-05 | 0.001134 |
335 | RESPONSE TO PEPTIDE | 39 | 404 | 8.329e-05 | 0.001157 |
336 | REGULATION OF RESPIRATORY SYSTEM PROCESS | 6 | 16 | 8.404e-05 | 0.001161 |
337 | CELL FATE COMMITMENT | 26 | 227 | 8.405e-05 | 0.001161 |
338 | REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION | 17 | 118 | 8.834e-05 | 0.001216 |
339 | CARDIOCYTE DIFFERENTIATION | 15 | 96 | 8.887e-05 | 0.00122 |
340 | TELENCEPHALON DEVELOPMENT | 26 | 228 | 9.043e-05 | 0.001238 |
341 | TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY | 23 | 190 | 9.161e-05 | 0.00125 |
342 | SENSORY ORGAN DEVELOPMENT | 45 | 493 | 9.312e-05 | 0.001267 |
343 | REGULATION OF BLOOD CIRCULATION | 31 | 295 | 9.484e-05 | 0.001287 |
344 | POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION | 20 | 154 | 9.784e-05 | 0.001321 |
345 | NEUROTROPHIN SIGNALING PATHWAY | 7 | 23 | 9.794e-05 | 0.001321 |
346 | REGULATION OF CELLULAR COMPONENT SIZE | 34 | 337 | 9.98e-05 | 0.001342 |
347 | PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS | 17 | 120 | 0.0001092 | 0.001461 |
348 | TRABECULA MORPHOGENESIS | 9 | 39 | 0.0001099 | 0.001461 |
349 | TISSUE REMODELING | 14 | 87 | 0.0001093 | 0.001461 |
350 | PEPTIDYL TYROSINE AUTOPHOSPHORYLATION | 9 | 39 | 0.0001099 | 0.001461 |
351 | RESPONSE TO ESTROGEN | 25 | 218 | 0.0001119 | 0.001484 |
352 | REGULATION OF MITOTIC CELL CYCLE | 43 | 468 | 0.0001142 | 0.00151 |
353 | REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT | 10 | 48 | 0.0001159 | 0.001515 |
354 | ACTOMYOSIN STRUCTURE ORGANIZATION | 13 | 77 | 0.0001155 | 0.001515 |
355 | PROSTATE GLAND GROWTH | 5 | 11 | 0.0001158 | 0.001515 |
356 | EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION | 5 | 11 | 0.0001158 | 0.001515 |
357 | NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION | 19 | 144 | 0.0001171 | 0.001526 |
358 | REGULATION OF CELL CYCLE PROCESS | 49 | 558 | 0.00012 | 0.00156 |
359 | NEGATIVE REGULATION OF ANOIKIS | 6 | 17 | 0.0001243 | 0.001607 |
360 | REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS | 6 | 17 | 0.0001243 | 0.001607 |
361 | MUSCLE CONTRACTION | 26 | 233 | 0.0001292 | 0.001661 |
362 | POSITIVE REGULATION OF CELL DEATH | 52 | 605 | 0.0001291 | 0.001661 |
363 | CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION | 7 | 24 | 0.0001323 | 0.001696 |
364 | EMBRYONIC SKELETAL SYSTEM DEVELOPMENT | 17 | 122 | 0.0001344 | 0.001718 |
365 | REGULATION OF CELL JUNCTION ASSEMBLY | 12 | 68 | 0.0001355 | 0.001723 |
366 | NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION | 9 | 40 | 0.0001356 | 0.001723 |
367 | POSITIVE REGULATION OF CELL CYCLE PROCESS | 27 | 247 | 0.0001368 | 0.001734 |
368 | NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION | 19 | 146 | 0.0001408 | 0.001781 |
369 | SINGLE ORGANISM CELL ADHESION | 42 | 459 | 0.0001494 | 0.001884 |
370 | CHEMICAL HOMEOSTASIS | 69 | 874 | 0.0001508 | 0.001896 |
371 | REGULATION OF JNK CASCADE | 20 | 159 | 0.0001525 | 0.001912 |
372 | REGULATION OF OSTEOBLAST DIFFERENTIATION | 16 | 112 | 0.000156 | 0.001951 |
373 | REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE | 23 | 197 | 0.0001586 | 0.001979 |
374 | REGULATION OF EXTENT OF CELL GROWTH | 15 | 101 | 0.0001598 | 0.001988 |
375 | RESPONSE TO MECHANICAL STIMULUS | 24 | 210 | 0.0001605 | 0.001991 |
376 | REGULATION OF CELL SIZE | 21 | 172 | 0.0001613 | 0.001996 |
377 | REGULATION OF MEMBRANE DEPOLARIZATION | 9 | 41 | 0.000166 | 0.002043 |
378 | LUNG ALVEOLUS DEVELOPMENT | 9 | 41 | 0.000166 | 0.002043 |
379 | REGULATION OF CELLULAR COMPONENT BIOGENESIS | 62 | 767 | 0.0001715 | 0.002105 |
380 | REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 7 | 25 | 0.0001758 | 0.002147 |
381 | NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY | 7 | 25 | 0.0001758 | 0.002147 |
382 | REGULATION OF GLUCOSE IMPORT | 11 | 60 | 0.0001798 | 0.002191 |
383 | REGENERATION | 20 | 161 | 0.0001809 | 0.002192 |
384 | NEURAL PRECURSOR CELL PROLIFERATION | 12 | 70 | 0.0001805 | 0.002192 |
385 | NEGATIVE REGULATION OF MITOTIC CELL CYCLE | 23 | 199 | 0.0001844 | 0.002229 |
386 | TAXIS | 42 | 464 | 0.0001888 | 0.002276 |
387 | EMBRYONIC ORGAN MORPHOGENESIS | 29 | 279 | 0.0001899 | 0.002278 |
388 | ACTIVATION OF PROTEIN KINASE ACTIVITY | 29 | 279 | 0.0001899 | 0.002278 |
389 | NEGATIVE REGULATION OF CHEMOTAXIS | 10 | 51 | 0.0001974 | 0.002355 |
390 | SEX DIFFERENTIATION | 28 | 266 | 0.000197 | 0.002355 |
391 | REGULATION OF MUSCLE TISSUE DEVELOPMENT | 15 | 103 | 0.0001997 | 0.002376 |
392 | DENDRITE MORPHOGENESIS | 9 | 42 | 0.0002019 | 0.002384 |
393 | REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL | 14 | 92 | 0.0002015 | 0.002384 |
394 | REGULATION OF HEART GROWTH | 9 | 42 | 0.0002019 | 0.002384 |
395 | CELLULAR RESPONSE TO ACID CHEMICAL | 21 | 175 | 0.0002056 | 0.002422 |
396 | ADHERENS JUNCTION ORGANIZATION | 12 | 71 | 0.0002074 | 0.002437 |
397 | REPRODUCTIVE SYSTEM DEVELOPMENT | 38 | 408 | 0.0002129 | 0.002495 |
398 | REGULATION OF NUCLEAR DIVISION | 20 | 163 | 0.0002139 | 0.002496 |
399 | NEGATIVE REGULATION OF CELL CYCLE PROCESS | 24 | 214 | 0.000214 | 0.002496 |
400 | REGULATION OF TRANSPORT | 124 | 1804 | 0.0002198 | 0.002557 |
401 | KIDNEY MORPHOGENESIS | 13 | 82 | 0.0002222 | 0.002572 |
402 | CARDIAC CONDUCTION | 13 | 82 | 0.0002222 | 0.002572 |
403 | HEART TRABECULA MORPHOGENESIS | 7 | 26 | 0.0002301 | 0.002631 |
404 | REPLACEMENT OSSIFICATION | 7 | 26 | 0.0002301 | 0.002631 |
405 | REGULATION OF MESENCHYMAL CELL PROLIFERATION | 8 | 34 | 0.0002292 | 0.002631 |
406 | POSITIVE REGULATION OF CATABOLIC PROCESS | 37 | 395 | 0.0002292 | 0.002631 |
407 | ENDOCHONDRAL OSSIFICATION | 7 | 26 | 0.0002301 | 0.002631 |
408 | REGULATION OF MUSCLE CELL APOPTOTIC PROCESS | 9 | 43 | 0.000244 | 0.002783 |
409 | NEGATIVE REGULATION OF CATABOLIC PROCESS | 23 | 203 | 0.0002474 | 0.002815 |
410 | REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY | 6 | 19 | 0.0002499 | 0.002836 |
411 | PALLIUM DEVELOPMENT | 19 | 153 | 0.0002608 | 0.002953 |
412 | REGULATION OF CARTILAGE DEVELOPMENT | 11 | 63 | 0.0002815 | 0.003171 |
413 | POSITIVE REGULATION OF JUN KINASE ACTIVITY | 11 | 63 | 0.0002815 | 0.003171 |
414 | RESPONSE TO INSULIN | 23 | 205 | 0.0002855 | 0.003209 |
415 | REGULATION OF RESPIRATORY GASEOUS EXCHANGE BY NEUROLOGICAL SYSTEM PROCESS | 5 | 13 | 0.0002964 | 0.003324 |
416 | POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION | 7 | 27 | 0.0002972 | 0.003324 |
417 | PHOSPHATIDYLINOSITOL METABOLIC PROCESS | 22 | 193 | 0.0003069 | 0.003424 |
418 | RESPONSE TO DRUG | 39 | 431 | 0.0003177 | 0.003537 |
419 | REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL | 10 | 54 | 0.0003223 | 0.003579 |
420 | BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS | 6 | 20 | 0.0003418 | 0.003787 |
421 | ACTIVATION OF GTPASE ACTIVITY | 12 | 75 | 0.0003517 | 0.003841 |
422 | ARTERY DEVELOPMENT | 12 | 75 | 0.0003517 | 0.003841 |
423 | SPROUTING ANGIOGENESIS | 9 | 45 | 0.0003503 | 0.003841 |
424 | SEMAPHORIN PLEXIN SIGNALING PATHWAY | 8 | 36 | 0.0003492 | 0.003841 |
425 | REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL | 12 | 75 | 0.0003517 | 0.003841 |
426 | NEGATIVE REGULATION OF CELL CYCLE | 39 | 433 | 0.0003484 | 0.003841 |
427 | EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 10 | 55 | 0.0003764 | 0.004101 |
428 | POSITIVE REGULATION OF ION TRANSPORT | 25 | 236 | 0.0003848 | 0.004183 |
429 | NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION | 14 | 98 | 0.0003944 | 0.004278 |
430 | NEGATIVE REGULATION OF KINASE ACTIVITY | 26 | 250 | 0.0003954 | 0.004279 |
431 | REGULATION OF CALCIUM MEDIATED SIGNALING | 12 | 76 | 0.0003987 | 0.004305 |
432 | NEGATIVE REGULATION OF NEURON DEATH | 20 | 171 | 0.0004048 | 0.00436 |
433 | LEUKOCYTE DIFFERENTIATION | 29 | 292 | 0.0004083 | 0.004388 |
434 | REGULATION OF CHONDROCYTE DIFFERENTIATION | 9 | 46 | 0.0004162 | 0.004452 |
435 | EMBRYONIC CRANIAL SKELETON MORPHOGENESIS | 9 | 46 | 0.0004162 | 0.004452 |
436 | RESPONSE TO STEROID HORMONE | 43 | 497 | 0.0004189 | 0.004471 |
437 | NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS | 11 | 66 | 0.0004278 | 0.004544 |
438 | NEGATIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY | 11 | 66 | 0.0004278 | 0.004544 |
439 | OUTFLOW TRACT MORPHOGENESIS | 10 | 56 | 0.0004378 | 0.00464 |
440 | CELL JUNCTION ORGANIZATION | 21 | 185 | 0.0004404 | 0.004657 |
441 | POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION | 13 | 88 | 0.0004525 | 0.004763 |
442 | REGULATION OF CATION CHANNEL ACTIVITY | 13 | 88 | 0.0004525 | 0.004763 |
443 | VESICLE MEDIATED TRANSPORT | 89 | 1239 | 0.0004542 | 0.004771 |
444 | POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE | 17 | 135 | 0.0004578 | 0.004792 |
445 | POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL | 6 | 21 | 0.0004583 | 0.004792 |
446 | POSITIVE REGULATION OF MITOTIC CELL CYCLE | 16 | 123 | 0.0004626 | 0.004815 |
447 | SECOND MESSENGER MEDIATED SIGNALING | 19 | 160 | 0.000462 | 0.004815 |
448 | RESPONSE TO EXTERNAL STIMULUS | 123 | 1821 | 0.0004666 | 0.004846 |
449 | EPITHELIAL CELL DEVELOPMENT | 21 | 186 | 0.0004734 | 0.004906 |
450 | RESPONSE TO ISCHEMIA | 7 | 29 | 0.0004782 | 0.004945 |
451 | DIGESTIVE SYSTEM DEVELOPMENT | 18 | 148 | 0.0004834 | 0.004987 |
452 | REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION | 14 | 100 | 0.0004866 | 0.005009 |
453 | REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION | 23 | 213 | 0.0004943 | 0.005077 |
454 | SEGMENTATION | 13 | 89 | 0.0005058 | 0.005184 |
455 | REGULATION OF CYTOSKELETON ORGANIZATION | 43 | 502 | 0.0005156 | 0.005266 |
456 | POSITIVE REGULATION OF ORGAN GROWTH | 8 | 38 | 0.0005161 | 0.005266 |
457 | NEGATIVE REGULATION OF MOLECULAR FUNCTION | 79 | 1079 | 0.000543 | 0.005529 |
458 | REGULATION OF LIPID KINASE ACTIVITY | 9 | 48 | 0.0005788 | 0.005881 |
459 | EMBRYONIC PATTERN SPECIFICATION | 10 | 58 | 0.0005856 | 0.005925 |
460 | MYELOID CELL DIFFERENTIATION | 21 | 189 | 0.0005857 | 0.005925 |
461 | CELL DIVISION | 40 | 460 | 0.0005941 | 0.00596 |
462 | NEGATIVE REGULATION OF CELL MATRIX ADHESION | 7 | 30 | 0.0005969 | 0.00596 |
463 | RESPONSE TO GROWTH HORMONE | 7 | 30 | 0.0005969 | 0.00596 |
464 | MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL | 7 | 30 | 0.0005969 | 0.00596 |
465 | POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION | 7 | 30 | 0.0005969 | 0.00596 |
466 | REGULATION OF HEART RATE BY CARDIAC CONDUCTION | 7 | 30 | 0.0005969 | 0.00596 |
467 | CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION | 6 | 22 | 0.0006034 | 0.005987 |
468 | SOMATIC STEM CELL DIVISION | 6 | 22 | 0.0006034 | 0.005987 |
469 | ACTIVATION OF PROTEIN KINASE B ACTIVITY | 6 | 22 | 0.0006034 | 0.005987 |
470 | NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY | 16 | 126 | 0.0006061 | 0.006 |
471 | NEGATIVE CHEMOTAXIS | 8 | 39 | 0.0006209 | 0.006134 |
472 | NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS | 5 | 15 | 0.0006356 | 0.0062 |
473 | ENDOCARDIAL CUSHION FORMATION | 5 | 15 | 0.0006356 | 0.0062 |
474 | REGULATION OF N METHYL D ASPARTATE SELECTIVE GLUTAMATE RECEPTOR ACTIVITY | 5 | 15 | 0.0006356 | 0.0062 |
475 | CELLULAR RESPONSE TO STEROL | 5 | 15 | 0.0006356 | 0.0062 |
476 | NEGATIVE REGULATION OF OSSIFICATION | 11 | 69 | 0.0006329 | 0.0062 |
477 | SYNAPSE ASSEMBLY | 11 | 69 | 0.0006329 | 0.0062 |
478 | RESPONSE TO LIPID | 67 | 888 | 0.0006501 | 0.006328 |
479 | MODULATION OF SYNAPTIC TRANSMISSION | 29 | 301 | 0.0006683 | 0.006492 |
480 | GLOMERULUS DEVELOPMENT | 9 | 49 | 0.0006778 | 0.006556 |
481 | CARDIAC SEPTUM MORPHOGENESIS | 9 | 49 | 0.0006778 | 0.006556 |
482 | CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT | 11 | 70 | 0.0007173 | 0.006924 |
483 | METANEPHROS DEVELOPMENT | 12 | 81 | 0.0007217 | 0.006938 |
484 | REGULATION OF JUN KINASE ACTIVITY | 12 | 81 | 0.0007217 | 0.006938 |
485 | SECRETION | 48 | 588 | 0.0007302 | 0.007005 |
486 | RESPONSE TO FIBROBLAST GROWTH FACTOR | 15 | 116 | 0.0007326 | 0.007014 |
487 | POSITIVE REGULATION OF CELL ADHESION | 34 | 376 | 0.0007571 | 0.007234 |
488 | REGULATION OF CELL GROWTH | 35 | 391 | 0.0007647 | 0.007291 |
489 | STEM CELL PROLIFERATION | 10 | 60 | 0.0007726 | 0.007306 |
490 | POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION | 10 | 60 | 0.0007726 | 0.007306 |
491 | CHONDROCYTE DIFFERENTIATION | 10 | 60 | 0.0007726 | 0.007306 |
492 | REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION | 10 | 60 | 0.0007726 | 0.007306 |
493 | REGULATION OF RESPIRATORY GASEOUS EXCHANGE | 6 | 23 | 0.0007818 | 0.007379 |
494 | REGULATION OF HEART CONTRACTION | 23 | 221 | 0.0008257 | 0.007778 |
495 | REGULATION OF PROTEIN CATABOLIC PROCESS | 35 | 393 | 0.0008371 | 0.007868 |
496 | POSITIVE REGULATION OF CALCIUM ION TRANSPORT | 14 | 106 | 0.0008803 | 0.008215 |
497 | POSITIVE REGULATION OF SYNAPSE ASSEMBLY | 10 | 61 | 0.000883 | 0.008215 |
498 | EAR DEVELOPMENT | 21 | 195 | 0.0008811 | 0.008215 |
499 | REGULATION OF MUSCLE SYSTEM PROCESS | 21 | 195 | 0.0008811 | 0.008215 |
500 | POSITIVE REGULATION OF STEM CELL PROLIFERATION | 10 | 61 | 0.000883 | 0.008215 |
501 | CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT | 5 | 16 | 0.0008863 | 0.008215 |
502 | BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS | 5 | 16 | 0.0008863 | 0.008215 |
503 | METANEPHRIC NEPHRON DEVELOPMENT | 7 | 32 | 0.0009037 | 0.008359 |
504 | NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS | 18 | 156 | 0.0009056 | 0.00836 |
505 | ENDOTHELIAL CELL DIFFERENTIATION | 11 | 72 | 0.0009142 | 0.008423 |
506 | POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY | 15 | 119 | 0.0009575 | 0.008805 |
507 | REGULATION OF SEQUESTERING OF CALCIUM ION | 14 | 107 | 0.0009668 | 0.008873 |
508 | NEGATIVE REGULATION OF CELL GROWTH | 19 | 170 | 0.0009752 | 0.008933 |
509 | REGULATION OF POSITIVE CHEMOTAXIS | 6 | 24 | 0.0009983 | 0.009073 |
510 | RESPONSE TO STEROL | 6 | 24 | 0.0009983 | 0.009073 |
511 | REGULATION OF ODONTOGENESIS | 6 | 24 | 0.0009983 | 0.009073 |
512 | REGULATION OF ANOIKIS | 6 | 24 | 0.0009983 | 0.009073 |
513 | SOMITOGENESIS | 10 | 62 | 0.001006 | 0.0091 |
514 | REGULATION OF NEURON DEATH | 25 | 252 | 0.001007 | 0.0091 |
515 | POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING | 10 | 62 | 0.001006 | 0.0091 |
516 | REGULATION OF ORGAN GROWTH | 11 | 73 | 0.001028 | 0.009272 |
517 | HORMONE MEDIATED SIGNALING PATHWAY | 18 | 158 | 0.001051 | 0.009437 |
518 | REGULATION OF LEUKOCYTE CHEMOTAXIS | 13 | 96 | 0.00105 | 0.009437 |
519 | IMMUNE SYSTEM PROCESS | 130 | 1984 | 0.001057 | 0.009473 |
520 | LEUKOCYTE ACTIVATION | 36 | 414 | 0.00109 | 0.009756 |
521 | EMBRYONIC AXIS SPECIFICATION | 7 | 33 | 0.001098 | 0.009775 |
522 | CELL ACTIVATION | 46 | 568 | 0.001099 | 0.009775 |
523 | EMBRYONIC DIGESTIVE TRACT DEVELOPMENT | 7 | 33 | 0.001098 | 0.009775 |
524 | REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION | 12 | 85 | 0.001117 | 0.009909 |
525 | IN UTERO EMBRYONIC DEVELOPMENT | 29 | 311 | 0.001118 | 0.009909 |
526 | POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE | 19 | 172 | 0.001122 | 0.009927 |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|
1 | PROTEIN DOMAIN SPECIFIC BINDING | 76 | 624 | 8.41e-13 | 7.813e-10 |
2 | KINASE BINDING | 71 | 606 | 3.01e-11 | 1.398e-08 |
3 | PROTEIN KINASE ACTIVITY | 70 | 640 | 8.738e-10 | 2.706e-07 |
4 | KINASE ACTIVITY | 84 | 842 | 1.609e-09 | 3.736e-07 |
5 | NUCLEIC ACID BINDING TRANSCRIPTION FACTOR ACTIVITY | 108 | 1199 | 2.419e-09 | 3.745e-07 |
6 | ENZYME BINDING | 143 | 1737 | 2.324e-09 | 3.745e-07 |
7 | PROTEIN TYROSINE KINASE ACTIVITY | 29 | 176 | 1.696e-08 | 2.251e-06 |
8 | RECEPTOR BINDING | 122 | 1476 | 3.294e-08 | 3.559e-06 |
9 | MACROMOLECULAR COMPLEX BINDING | 117 | 1399 | 3.448e-08 | 3.559e-06 |
10 | TRANSCRIPTION FACTOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING | 41 | 328 | 8.202e-08 | 7.62e-06 |
11 | MOLECULAR FUNCTION REGULATOR | 112 | 1353 | 1.19e-07 | 1.005e-05 |
12 | PROTEIN COMPLEX BINDING | 84 | 935 | 1.829e-07 | 1.416e-05 |
13 | TRANSFERASE ACTIVITY TRANSFERRING PHOSPHORUS CONTAINING GROUPS | 86 | 992 | 5.942e-07 | 4.246e-05 |
14 | SH3 DOMAIN BINDING | 20 | 116 | 1.324e-06 | 8.786e-05 |
15 | PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY | 15 | 70 | 1.67e-06 | 0.0001034 |
16 | PDZ DOMAIN BINDING | 17 | 90 | 2.228e-06 | 0.0001294 |
17 | TRANSMEMBRANE RECEPTOR PROTEIN KINASE ACTIVITY | 16 | 81 | 2.382e-06 | 0.0001302 |
18 | CALCIUM ION BINDING | 64 | 697 | 2.698e-06 | 0.0001393 |
19 | RNA POLYMERASE II TRANSCRIPTION FACTOR ACTIVITY SEQUENCE SPECIFIC DNA BINDING | 59 | 629 | 3.429e-06 | 0.0001593 |
20 | GROWTH FACTOR BINDING | 20 | 123 | 3.396e-06 | 0.0001593 |
21 | GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY | 35 | 303 | 4.458e-06 | 0.0001972 |
22 | CYTOSKELETAL PROTEIN BINDING | 71 | 819 | 5.908e-06 | 0.0002495 |
23 | X1 PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY | 11 | 43 | 6.621e-06 | 0.0002674 |
24 | RAS GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY | 28 | 228 | 1.268e-05 | 0.0004907 |
25 | ZINC ION BINDING | 91 | 1155 | 1.447e-05 | 0.0005376 |
26 | COLLAGEN BINDING | 13 | 65 | 1.807e-05 | 0.0006458 |
27 | REGULATORY REGION NUCLEIC ACID BINDING | 69 | 818 | 1.964e-05 | 0.0006759 |
28 | TRANSCRIPTION FACTOR BINDING | 49 | 524 | 2.486e-05 | 0.0008249 |
29 | DOUBLE STRANDED DNA BINDING | 65 | 764 | 2.63e-05 | 0.0008427 |
30 | VOLTAGE GATED SODIUM CHANNEL ACTIVITY | 7 | 20 | 3.538e-05 | 0.001096 |
31 | PHOSPHATIDYLINOSITOL KINASE ACTIVITY | 11 | 51 | 3.785e-05 | 0.001134 |
32 | BHLH TRANSCRIPTION FACTOR BINDING | 8 | 28 | 5.136e-05 | 0.001491 |
33 | SULFUR COMPOUND BINDING | 27 | 234 | 5.448e-05 | 0.001534 |
34 | RECEPTOR SIGNALING PROTEIN ACTIVITY | 22 | 172 | 5.656e-05 | 0.001545 |
35 | TRANSITION METAL ION BINDING | 103 | 1400 | 6.503e-05 | 0.001726 |
36 | TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY | 12 | 64 | 7.358e-05 | 0.001899 |
37 | IDENTICAL PROTEIN BINDING | 91 | 1209 | 7.914e-05 | 0.001935 |
38 | TRANSCRIPTIONAL ACTIVATOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING | 26 | 226 | 7.809e-05 | 0.001935 |
39 | SEQUENCE SPECIFIC DNA BINDING | 80 | 1037 | 9.76e-05 | 0.002325 |
40 | ACTIVATING TRANSCRIPTION FACTOR BINDING | 11 | 57 | 0.0001112 | 0.002582 |
41 | EPHRIN RECEPTOR BINDING | 7 | 24 | 0.0001323 | 0.002997 |
42 | TRANSCRIPTIONAL ACTIVATOR ACTIVITY RNA POLYMERASE II TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC BINDING | 32 | 315 | 0.0001391 | 0.003076 |
43 | BINDING BRIDGING | 21 | 173 | 0.000175 | 0.003781 |
44 | TRANSCRIPTION FACTOR ACTIVITY PROTEIN BINDING | 50 | 588 | 0.0002232 | 0.004607 |
45 | RNA POLYMERASE II TRANSCRIPTION FACTOR BINDING | 15 | 104 | 0.0002226 | 0.004607 |
46 | SMAD BINDING | 12 | 72 | 0.0002376 | 0.004778 |
47 | RIBONUCLEOTIDE BINDING | 127 | 1860 | 0.0002417 | 0.004778 |
48 | TRANSCRIPTIONAL REPRESSOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING | 15 | 105 | 0.0002479 | 0.004797 |
49 | CHEMOREPELLENT ACTIVITY | 7 | 27 | 0.0002972 | 0.005635 |
50 | PROTEIN SERINE THREONINE KINASE ACTIVITY | 40 | 445 | 0.0003067 | 0.005698 |
51 | RNA POLYMERASE II ACTIVATING TRANSCRIPTION FACTOR BINDING | 8 | 36 | 0.0003492 | 0.006361 |
52 | HORMONE BINDING | 11 | 65 | 0.0003732 | 0.006668 |
53 | ACTIN BINDING | 36 | 393 | 0.0004227 | 0.00733 |
54 | SODIUM CHANNEL ACTIVITY | 8 | 37 | 0.000426 | 0.00733 |
55 | CORECEPTOR ACTIVITY | 8 | 38 | 0.0005161 | 0.008717 |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|
1 | CELL JUNCTION | 110 | 1151 | 5.334e-11 | 3.115e-08 |
2 | EXCITATORY SYNAPSE | 33 | 197 | 1.148e-09 | 2.728e-07 |
3 | NEURON PROJECTION | 91 | 942 | 1.652e-09 | 2.728e-07 |
4 | MEMBRANE REGION | 104 | 1134 | 1.869e-09 | 2.728e-07 |
5 | NEURON PART | 112 | 1265 | 3.157e-09 | 3.687e-07 |
6 | SYNAPSE | 76 | 754 | 6.417e-09 | 6.246e-07 |
7 | POSTSYNAPSE | 47 | 378 | 1.101e-08 | 9.189e-07 |
8 | MEMBRANE MICRODOMAIN | 39 | 288 | 1.928e-08 | 1.407e-06 |
9 | PROTEINACEOUS EXTRACELLULAR MATRIX | 44 | 356 | 3.867e-08 | 2.509e-06 |
10 | INTRINSIC COMPONENT OF PLASMA MEMBRANE | 130 | 1649 | 1.711e-07 | 9.99e-06 |
11 | SARCOLEMMA | 22 | 125 | 2.738e-07 | 1.454e-05 |
12 | EXTRACELLULAR MATRIX | 47 | 426 | 4.17e-07 | 2.029e-05 |
13 | GOLGI APPARATUS | 115 | 1445 | 5.995e-07 | 2.693e-05 |
14 | CELL PROJECTION | 135 | 1786 | 1.02e-06 | 4.256e-05 |
15 | PLASMA MEMBRANE RAFT | 17 | 86 | 1.148e-06 | 4.469e-05 |
16 | ACTIN CYTOSKELETON | 47 | 444 | 1.358e-06 | 4.665e-05 |
17 | SYNAPSE PART | 59 | 610 | 1.292e-06 | 4.665e-05 |
18 | CYTOSKELETON | 145 | 1967 | 1.594e-06 | 5.172e-05 |
19 | SOMATODENDRITIC COMPARTMENT | 59 | 650 | 9.41e-06 | 0.0002892 |
20 | T TUBULE | 11 | 45 | 1.065e-05 | 0.000311 |
21 | CELL CELL JUNCTION | 40 | 383 | 1.13e-05 | 0.0003143 |
22 | PLASMA MEMBRANE REGION | 77 | 929 | 1.205e-05 | 0.0003198 |
23 | CELL PROJECTION PART | 77 | 946 | 2.26e-05 | 0.0005637 |
24 | DENDRITE | 44 | 451 | 2.317e-05 | 0.0005637 |
25 | VOLTAGE GATED SODIUM CHANNEL COMPLEX | 6 | 14 | 3.439e-05 | 0.0008032 |
26 | AXON | 41 | 418 | 3.855e-05 | 0.0008658 |
27 | CELL SUBSTRATE JUNCTION | 39 | 398 | 6.033e-05 | 0.001305 |
28 | CELL CELL CONTACT ZONE | 12 | 64 | 7.358e-05 | 0.001535 |
29 | EXTRINSIC COMPONENT OF MEMBRANE | 28 | 252 | 7.806e-05 | 0.001563 |
30 | ENDOSOME | 65 | 793 | 8.028e-05 | 0.001563 |
31 | PLASMA MEMBRANE PROTEIN COMPLEX | 46 | 510 | 0.0001035 | 0.00195 |
32 | SODIUM CHANNEL COMPLEX | 6 | 17 | 0.0001243 | 0.002145 |
33 | CELL SURFACE | 62 | 757 | 0.0001194 | 0.002145 |
34 | RECEPTOR COMPLEX | 33 | 327 | 0.0001249 | 0.002145 |
35 | MAIN AXON | 11 | 58 | 0.000131 | 0.002186 |
36 | ANCHORING JUNCTION | 44 | 489 | 0.0001532 | 0.002486 |
37 | SITE OF POLARIZED GROWTH | 19 | 149 | 0.0001845 | 0.002762 |
38 | EXTRACELLULAR MATRIX COMPONENT | 17 | 125 | 0.0001815 | 0.002762 |
39 | ACTIN FILAMENT | 12 | 70 | 0.0001805 | 0.002762 |
40 | VACUOLE | 87 | 1180 | 0.0002279 | 0.003327 |
41 | ACTOMYOSIN | 11 | 62 | 0.0002433 | 0.003465 |
42 | POSTSYNAPTIC MEMBRANE | 23 | 205 | 0.0002855 | 0.00397 |
43 | AXON PART | 24 | 219 | 0.0003029 | 0.004113 |
44 | GLYCOPROTEIN COMPLEX | 6 | 21 | 0.0004583 | 0.00601 |
45 | GOLGI APPARATUS PART | 68 | 893 | 0.0004631 | 0.00601 |
46 | PERINUCLEAR REGION OF CYTOPLASM | 52 | 642 | 0.0005358 | 0.006756 |
47 | SIDE OF MEMBRANE | 38 | 428 | 0.0005437 | 0.006756 |
48 | APICAL JUNCTION COMPLEX | 16 | 128 | 0.0007215 | 0.008779 |
49 | BASEMENT MEMBRANE | 13 | 93 | 0.0007757 | 0.009246 |
Num | Pathway | Pathview | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|---|
1 | hsa04115_p53_signaling_pathway | 14 | 69 | 7.269e-06 | 0.0004948 | |
2 | hsa04151_PI3K_AKT_signaling_pathway | 38 | 351 | 8.194e-06 | 0.0004948 | |
3 | hsa04510_Focal_adhesion | 26 | 200 | 9.269e-06 | 0.0004948 | |
4 | hsa04630_Jak.STAT_signaling_pathway | 22 | 155 | 1.1e-05 | 0.0004948 | |
5 | hsa04014_Ras_signaling_pathway | 27 | 236 | 6.313e-05 | 0.002067 | |
6 | hsa04722_Neurotrophin_signaling_pathway | 18 | 127 | 6.891e-05 | 0.002067 | |
7 | hsa04010_MAPK_signaling_pathway | 28 | 268 | 0.0002233 | 0.005741 | |
8 | hsa04914_Progesterone.mediated_oocyte_maturation | 13 | 87 | 0.0004039 | 0.009089 | |
9 | hsa04114_Oocyte_meiosis | 15 | 114 | 0.000609 | 0.01218 | |
10 | hsa04390_Hippo_signaling_pathway | 18 | 154 | 0.000778 | 0.01399 | |
11 | hsa04360_Axon_guidance | 16 | 130 | 0.0008552 | 0.01399 | |
12 | hsa04514_Cell_adhesion_molecules_.CAMs. | 16 | 136 | 0.001389 | 0.02084 | |
13 | hsa04110_Cell_cycle | 15 | 128 | 0.00201 | 0.02783 | |
14 | hsa04520_Adherens_junction | 10 | 73 | 0.003532 | 0.04278 | |
15 | hsa04512_ECM.receptor_interaction | 11 | 85 | 0.003565 | 0.04278 | |
16 | hsa04710_Circadian_rhythm_._mammal | 5 | 23 | 0.00509 | 0.05726 | |
17 | hsa04720_Long.term_potentiation | 9 | 70 | 0.008371 | 0.08863 | |
18 | hsa04310_Wnt_signaling_pathway | 15 | 151 | 0.00944 | 0.0944 | |
19 | hsa04380_Osteoclast_differentiation | 13 | 128 | 0.01265 | 0.1198 | |
20 | hsa04350_TGF.beta_signaling_pathway | 9 | 85 | 0.02729 | 0.2333 | |
21 | hsa04144_Endocytosis | 17 | 203 | 0.02836 | 0.2333 | |
22 | hsa04012_ErbB_signaling_pathway | 9 | 87 | 0.03114 | 0.2333 | |
23 | hsa04972_Pancreatic_secretion | 10 | 101 | 0.03119 | 0.2333 | |
24 | hsa04270_Vascular_smooth_muscle_contraction | 11 | 116 | 0.03246 | 0.2333 | |
25 | hsa04971_Gastric_acid_secretion | 8 | 74 | 0.03255 | 0.2333 | |
26 | hsa04020_Calcium_signaling_pathway | 15 | 177 | 0.03457 | 0.2333 | |
27 | hsa04970_Salivary_secretion | 9 | 89 | 0.03535 | 0.2333 | |
28 | hsa00604_Glycosphingolipid_biosynthesis_._ganglio_series | 3 | 15 | 0.03697 | 0.2333 | |
29 | hsa04540_Gap_junction | 9 | 90 | 0.03759 | 0.2333 | |
30 | hsa04810_Regulation_of_actin_cytoskeleton | 17 | 214 | 0.04348 | 0.2609 | |
31 | hsa04150_mTOR_signaling_pathway | 6 | 52 | 0.04595 | 0.2668 | |
32 | hsa04340_Hedgehog_signaling_pathway | 6 | 56 | 0.06205 | 0.349 | |
33 | hsa04912_GnRH_signaling_pathway | 9 | 101 | 0.06882 | 0.3644 | |
34 | hsa04916_Melanogenesis | 9 | 101 | 0.06882 | 0.3644 | |
35 | hsa00072_Synthesis_and_degradation_of_ketone_bodies | 2 | 9 | 0.07231 | 0.3719 | |
36 | hsa04330_Notch_signaling_pathway | 5 | 47 | 0.08681 | 0.4341 | |
37 | hsa04910_Insulin_signaling_pathway | 11 | 138 | 0.08962 | 0.436 | |
38 | hsa04660_T_cell_receptor_signaling_pathway | 9 | 108 | 0.09526 | 0.4512 | |
39 | hsa04070_Phosphatidylinositol_signaling_system | 7 | 78 | 0.09819 | 0.4532 | |
40 | hsa00740_Riboflavin_metabolism | 2 | 11 | 0.1034 | 0.4654 | |
41 | hsa00603_Glycosphingolipid_biosynthesis_._globo_series | 2 | 14 | 0.1552 | 0.6711 | |
42 | hsa00562_Inositol_phosphate_metabolism | 5 | 57 | 0.1593 | 0.6711 | |
43 | hsa04960_Aldosterone.regulated_sodium_reabsorption | 4 | 42 | 0.1603 | 0.6711 | |
44 | hsa04370_VEGF_signaling_pathway | 6 | 76 | 0.1846 | 0.7365 | |
45 | hsa00512_Mucin_type_O.Glycan_biosynthesis | 3 | 30 | 0.1912 | 0.7365 | |
46 | hsa00770_Pantothenate_and_CoA_biosynthesis | 2 | 16 | 0.1918 | 0.7365 | |
47 | hsa04260_Cardiac_muscle_contraction | 6 | 77 | 0.1923 | 0.7365 | |
48 | hsa00450_Selenocompound_metabolism | 2 | 17 | 0.2106 | 0.7897 | |
49 | hsa04530_Tight_junction | 9 | 133 | 0.2291 | 0.8235 | |
50 | hsa00670_One_carbon_pool_by_folate | 2 | 18 | 0.2295 | 0.8235 | |
51 | hsa04672_Intestinal_immune_network_for_IgA_production | 4 | 49 | 0.2333 | 0.8235 | |
52 | hsa04062_Chemokine_signaling_pathway | 12 | 189 | 0.2468 | 0.8544 | |
53 | hsa03030_DNA_replication | 3 | 36 | 0.2723 | 0.9248 | |
54 | hsa04730_Long.term_depression | 5 | 70 | 0.278 | 0.9265 | |
55 | hsa04976_Bile_secretion | 5 | 71 | 0.2878 | 0.9412 | |
56 | hsa04210_Apoptosis | 6 | 89 | 0.2928 | 0.9412 | |
57 | hsa00532_Glycosaminoglycan_biosynthesis_._chondroitin_sulfate | 2 | 22 | 0.3056 | 0.965 | |
58 | hsa04320_Dorso.ventral_axis_formation | 2 | 25 | 0.3618 | 1 | |
59 | hsa00310_Lysine_degradation | 3 | 44 | 0.3841 | 1 | |
60 | hsa02010_ABC_transporters | 3 | 44 | 0.3841 | 1 | |
61 | hsa04962_Vasopressin.regulated_water_reabsorption | 3 | 44 | 0.3841 | 1 | |
62 | hsa04973_Carbohydrate_digestion_and_absorption | 3 | 44 | 0.3841 | 1 | |
63 | hsa04974_Protein_digestion_and_absorption | 5 | 81 | 0.3885 | 1 | |
64 | hsa04620_Toll.like_receptor_signaling_pathway | 6 | 102 | 0.4103 | 1 | |
65 | hsa04920_Adipocytokine_signaling_pathway | 4 | 68 | 0.4509 | 1 | |
66 | hsa00650_Butanoate_metabolism | 2 | 30 | 0.4512 | 1 | |
67 | hsa04610_Complement_and_coagulation_cascades | 4 | 69 | 0.4621 | 1 | |
68 | hsa03410_Base_excision_repair | 2 | 34 | 0.5174 | 1 | |
69 | hsa04662_B_cell_receptor_signaling_pathway | 4 | 75 | 0.5276 | 1 | |
70 | hsa04650_Natural_killer_cell_mediated_cytotoxicity | 7 | 136 | 0.5332 | 1 | |
71 | hsa00270_Cysteine_and_methionine_metabolism | 2 | 36 | 0.5484 | 1 | |
72 | hsa04130_SNARE_interactions_in_vesicular_transport | 2 | 36 | 0.5484 | 1 | |
73 | hsa03022_Basal_transcription_factors | 2 | 37 | 0.5634 | 1 | |
74 | hsa00230_Purine_metabolism | 8 | 162 | 0.5757 | 1 | |
75 | hsa00590_Arachidonic_acid_metabolism | 3 | 59 | 0.5776 | 1 | |
76 | hsa00830_Retinol_metabolism | 3 | 64 | 0.633 | 1 | |
77 | hsa00071_Fatty_acid_metabolism | 2 | 43 | 0.6457 | 1 | |
78 | hsa04640_Hematopoietic_cell_lineage | 4 | 88 | 0.6544 | 1 | |
79 | hsa00280_Valine._leucine_and_isoleucine_degradation | 2 | 44 | 0.6582 | 1 | |
80 | hsa04145_Phagosome | 7 | 156 | 0.6776 | 1 | |
81 | hsa03018_RNA_degradation | 3 | 71 | 0.7018 | 1 | |
82 | hsa04120_Ubiquitin_mediated_proteolysis | 6 | 139 | 0.7084 | 1 | |
83 | hsa04666_Fc_gamma_R.mediated_phagocytosis | 4 | 95 | 0.7124 | 1 | |
84 | hsa00510_N.Glycan_biosynthesis | 2 | 49 | 0.7152 | 1 | |
85 | hsa00561_Glycerolipid_metabolism | 2 | 50 | 0.7256 | 1 | |
86 | hsa00983_Drug_metabolism_._other_enzymes | 2 | 52 | 0.7455 | 1 | |
87 | hsa04141_Protein_processing_in_endoplasmic_reticulum | 7 | 168 | 0.7492 | 1 | |
88 | hsa04664_Fc_epsilon_RI_signaling_pathway | 3 | 79 | 0.7679 | 1 | |
89 | hsa00564_Glycerophospholipid_metabolism | 3 | 80 | 0.7753 | 1 | |
90 | hsa04623_Cytosolic_DNA.sensing_pathway | 2 | 56 | 0.7815 | 1 | |
91 | hsa00970_Aminoacyl.tRNA_biosynthesis | 2 | 63 | 0.8338 | 1 | |
92 | hsa04670_Leukocyte_transendothelial_migration | 4 | 117 | 0.8476 | 1 | |
93 | hsa04622_RIG.I.like_receptor_signaling_pathway | 2 | 71 | 0.8795 | 1 | |
94 | hsa00240_Pyrimidine_metabolism | 3 | 99 | 0.882 | 1 | |
95 | hsa00982_Drug_metabolism_._cytochrome_P450 | 2 | 73 | 0.889 | 1 | |
96 | hsa04146_Peroxisome | 2 | 79 | 0.9134 | 1 | |
97 | hsa03008_Ribosome_biogenesis_in_eukaryotes | 2 | 81 | 0.9203 | 1 | |
98 | hsa03010_Ribosome | 2 | 92 | 0.9501 | 1 | |
99 | hsa04142_Lysosome | 2 | 121 | 0.9861 | 1 | |
100 | hsa04740_Olfactory_transduction | 2 | 388 | 1 | 1 |
Num | lncRNA | miRNAs | miRNAs count | Gene | Sponge regulatory network | lncRNA log2FC | lncRNA pvalue | Gene log2FC | Gene pvalue | lncRNA-gene Pearson correlation |
---|---|---|---|---|---|---|---|---|---|---|
1 | TINCR | hsa-let-7e-5p;hsa-miR-106a-5p;hsa-miR-125a-3p;hsa-miR-148b-3p;hsa-miR-200b-3p;hsa-miR-20b-5p;hsa-miR-217;hsa-miR-30a-3p;hsa-miR-335-5p;hsa-miR-592 | 10 | MXD1 | Sponge network | 3.51 | 0.03668 | 1.612 | 0.03992 | 0.575 |
2 | CALML3-AS1 | hsa-let-7e-5p;hsa-miR-106a-5p;hsa-miR-125a-3p;hsa-miR-148b-3p;hsa-miR-20b-5p;hsa-miR-217;hsa-miR-30a-3p;hsa-miR-335-5p;hsa-miR-589-3p;hsa-miR-592 | 10 | MXD1 | Sponge network | 4.924 | 0.00575 | 1.612 | 0.03992 | 0.526 |
3 | RP11-760H22.2 | hsa-let-7f-1-3p;hsa-miR-130b-3p;hsa-miR-17-5p;hsa-miR-18a-5p;hsa-miR-193a-5p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-31-5p;hsa-miR-32-3p;hsa-miR-7-5p;hsa-miR-9-3p | 11 | ESR1 | Sponge network | -3.418 | 0.00912 | -4.867 | 9.0E-5 | 0.515 |
4 | HAND2-AS1 |
hsa-let-7f-1-3p;hsa-miR-107;hsa-miR-130b-3p;hsa-miR-130b-5p;hsa-miR-17-5p;hsa-miR-188-5p;hsa-miR-18a-3p;hsa-miR-18a-5p;hsa-miR-193a-3p;hsa-miR-193a-5p;hsa-miR-193b-3p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-21-3p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-301a-3p;hsa-miR-31-5p;hsa-miR-32-3p;hsa-miR-324-5p;hsa-miR-330-3p;hsa-miR-33a-3p;hsa-miR-590-3p;hsa-miR-629-3p;hsa-miR-7-5p | 25 | ESR1 | Sponge network | -7.871 | 0 | -4.867 | 9.0E-5 | 0.509 |
5 | RP11-130L8.1 |
hsa-let-7f-1-3p;hsa-miR-107;hsa-miR-130b-3p;hsa-miR-130b-5p;hsa-miR-17-5p;hsa-miR-181b-5p;hsa-miR-18a-5p;hsa-miR-193a-5p;hsa-miR-193b-3p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-590-3p | 12 | ESR1 | Sponge network | -4.329 | 1.0E-5 | -4.867 | 9.0E-5 | 0.491 |
6 | EMX2OS |
hsa-let-7f-1-3p;hsa-miR-107;hsa-miR-130b-3p;hsa-miR-17-5p;hsa-miR-18a-3p;hsa-miR-18a-5p;hsa-miR-193a-3p;hsa-miR-193a-5p;hsa-miR-193b-3p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-21-3p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-301a-3p;hsa-miR-31-5p;hsa-miR-32-3p;hsa-miR-324-5p;hsa-miR-330-3p;hsa-miR-33a-3p;hsa-miR-454-3p;hsa-miR-589-3p;hsa-miR-590-3p;hsa-miR-629-3p;hsa-miR-7-5p | 25 | ESR1 | Sponge network | -6.205 | 0.00015 | -4.867 | 9.0E-5 | 0.471 |
7 | LINC00284 |
hsa-let-7f-1-3p;hsa-miR-17-5p;hsa-miR-18a-3p;hsa-miR-18a-5p;hsa-miR-193a-3p;hsa-miR-193a-5p;hsa-miR-193b-3p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-21-3p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-31-5p;hsa-miR-32-3p;hsa-miR-330-3p;hsa-miR-589-3p;hsa-miR-590-3p;hsa-miR-629-3p;hsa-miR-7-5p | 19 | ESR1 | Sponge network | -5.478 | 0.02716 | -4.867 | 9.0E-5 | 0.454 |
8 | BDNF-AS | hsa-let-7f-1-3p;hsa-miR-17-5p;hsa-miR-18a-3p;hsa-miR-18a-5p;hsa-miR-193a-3p;hsa-miR-193a-5p;hsa-miR-193b-3p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-31-5p;hsa-miR-589-3p;hsa-miR-590-3p;hsa-miR-629-3p | 15 | ESR1 | Sponge network | -1.712 | 0.02515 | -4.867 | 9.0E-5 | 0.441 |
9 | ZNF667-AS1 |
hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-18a-3p;hsa-miR-18a-5p;hsa-miR-193a-3p;hsa-miR-193b-3p;hsa-miR-21-5p;hsa-miR-222-5p;hsa-miR-27a-3p;hsa-miR-484;hsa-miR-590-5p;hsa-miR-627-5p | 14 | TGFBR3 | Sponge network | -4.019 | 0.00137 | -4.817 | 0 | 0.44 |
10 | RP11-757G1.6 |
hsa-let-7f-1-3p;hsa-miR-18a-5p;hsa-miR-193a-3p;hsa-miR-193a-5p;hsa-miR-193b-3p;hsa-miR-21-3p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-31-5p;hsa-miR-33a-3p;hsa-miR-590-3p;hsa-miR-629-3p;hsa-miR-9-3p | 13 | ESR1 | Sponge network | -2.705 | 0.04664 | -4.867 | 9.0E-5 | 0.412 |
11 | CTB-92J24.3 |
hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-18a-3p;hsa-miR-18a-5p;hsa-miR-21-5p;hsa-miR-222-5p;hsa-miR-33a-3p;hsa-miR-627-5p;hsa-miR-944 | 11 | TGFBR3 | Sponge network | -7.226 | 0.0046 | -4.817 | 0 | 0.405 |
12 | RP11-355F16.1 | hsa-let-7f-1-3p;hsa-miR-17-5p;hsa-miR-18a-3p;hsa-miR-18a-5p;hsa-miR-193a-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-21-3p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-32-3p;hsa-miR-330-3p;hsa-miR-590-3p;hsa-miR-629-3p | 14 | ESR1 | Sponge network | -2.178 | 0.07502 | -4.867 | 9.0E-5 | 0.402 |
13 | RP11-1036E20.9 | hsa-miR-17-5p;hsa-miR-181b-5p;hsa-miR-18a-3p;hsa-miR-18a-5p;hsa-miR-193a-3p;hsa-miR-193a-5p;hsa-miR-193b-3p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-32-3p;hsa-miR-7-5p | 13 | ESR1 | Sponge network | -0.331 | 0.90522 | -4.867 | 9.0E-5 | 0.4 |
14 | CTD-2554C21.2 |
hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-18a-3p;hsa-miR-18a-5p;hsa-miR-193a-3p;hsa-miR-193b-3p;hsa-miR-222-5p;hsa-miR-27a-3p;hsa-miR-944 | 11 | TGFBR3 | Sponge network | -6.968 | 0.00817 | -4.817 | 0 | 0.396 |
15 | RASSF8-AS1 | hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-18a-5p;hsa-miR-193a-3p;hsa-miR-21-5p;hsa-miR-222-5p;hsa-miR-27a-3p;hsa-miR-27b-3p;hsa-miR-33a-3p;hsa-miR-590-3p;hsa-miR-944 | 13 | TGFBR3 | Sponge network | -2.562 | 0.00163 | -4.817 | 0 | 0.393 |
16 | RP1-193H18.2 | hsa-let-7f-1-3p;hsa-miR-18a-3p;hsa-miR-18a-5p;hsa-miR-193a-3p;hsa-miR-193a-5p;hsa-miR-193b-3p;hsa-miR-21-3p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-31-5p;hsa-miR-629-3p;hsa-miR-7-5p | 12 | ESR1 | Sponge network | -0.388 | 0.6877 | -4.867 | 9.0E-5 | 0.39 |
17 | RP11-359B12.2 |
hsa-miR-15a-5p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-18a-3p;hsa-miR-18a-5p;hsa-miR-193a-3p;hsa-miR-193b-3p;hsa-miR-21-5p;hsa-miR-222-5p;hsa-miR-27a-3p;hsa-miR-484;hsa-miR-590-3p;hsa-miR-590-5p | 13 | TGFBR3 | Sponge network | -2.094 | 0.00033 | -4.817 | 0 | 0.38 |
18 | NR2F2-AS1 |
hsa-let-7f-1-3p;hsa-miR-17-5p;hsa-miR-18a-3p;hsa-miR-18a-5p;hsa-miR-193a-3p;hsa-miR-193a-5p;hsa-miR-193b-3p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-21-3p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-31-5p;hsa-miR-590-3p;hsa-miR-629-3p;hsa-miR-7-5p;hsa-miR-9-3p | 17 | ESR1 | Sponge network | -3.785 | 0.00281 | -4.867 | 9.0E-5 | 0.376 |
19 | RP11-166D19.1 |
hsa-let-7f-1-3p;hsa-miR-107;hsa-miR-130b-3p;hsa-miR-130b-5p;hsa-miR-17-5p;hsa-miR-188-5p;hsa-miR-18a-3p;hsa-miR-18a-5p;hsa-miR-193a-3p;hsa-miR-193a-5p;hsa-miR-193b-3p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-301a-3p;hsa-miR-32-3p;hsa-miR-33a-3p;hsa-miR-454-3p;hsa-miR-589-3p;hsa-miR-590-3p;hsa-miR-629-3p;hsa-miR-9-5p | 23 | ESR1 | Sponge network | -4.209 | 2.0E-5 | -4.867 | 9.0E-5 | 0.374 |
20 | RP11-747H7.3 | hsa-let-7f-1-3p;hsa-miR-130b-3p;hsa-miR-130b-5p;hsa-miR-18a-3p;hsa-miR-193b-3p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-32-3p;hsa-miR-7-5p;hsa-miR-9-3p;hsa-miR-9-5p | 11 | ESR1 | Sponge network | -0.36 | 0.74172 | -4.867 | 9.0E-5 | 0.371 |
21 | RP11-680F20.6 |
hsa-miR-130b-3p;hsa-miR-17-5p;hsa-miR-188-5p;hsa-miR-18a-3p;hsa-miR-18a-5p;hsa-miR-193a-3p;hsa-miR-193b-3p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-301a-3p;hsa-miR-9-5p | 11 | ESR1 | Sponge network | -3.912 | 0.17114 | -4.867 | 9.0E-5 | 0.37 |
22 | MAGI2-AS3 |
hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-18a-3p;hsa-miR-18a-5p;hsa-miR-193a-3p;hsa-miR-193b-3p;hsa-miR-21-5p;hsa-miR-222-5p;hsa-miR-27a-3p;hsa-miR-33a-3p;hsa-miR-590-3p | 13 | TGFBR3 | Sponge network | -4.563 | 0 | -4.817 | 0 | 0.366 |
23 | RP11-627G23.1 | hsa-let-7f-1-3p;hsa-miR-17-5p;hsa-miR-18a-3p;hsa-miR-18a-5p;hsa-miR-193a-3p;hsa-miR-193b-3p;hsa-miR-21-3p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-31-5p;hsa-miR-330-3p;hsa-miR-33a-3p;hsa-miR-629-3p;hsa-miR-9-3p;hsa-miR-9-5p | 15 | ESR1 | Sponge network | -4.055 | 0.12629 | -4.867 | 9.0E-5 | 0.365 |
24 | RP11-554A11.4 | hsa-miR-107;hsa-miR-130b-5p;hsa-miR-17-5p;hsa-miR-18a-3p;hsa-miR-193a-3p;hsa-miR-193a-5p;hsa-miR-193b-3p;hsa-miR-222-3p;hsa-miR-32-3p;hsa-miR-33a-3p;hsa-miR-629-3p | 11 | ESR1 | Sponge network | -5.361 | 2.0E-5 | -4.867 | 9.0E-5 | 0.363 |
25 | MIR143HG |
hsa-miR-148b-3p;hsa-miR-16-2-3p;hsa-miR-200b-3p;hsa-miR-224-3p;hsa-miR-3065-5p;hsa-miR-30b-5p;hsa-miR-30c-5p;hsa-miR-30d-5p;hsa-miR-30e-5p;hsa-miR-3607-3p | 10 | INHBA | Sponge network | -6.51 | 0 | 0.597 | 0.64331 | 0.362 |
26 | NR2F2-AS1 |
hsa-miR-15a-5p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-18a-3p;hsa-miR-18a-5p;hsa-miR-193a-3p;hsa-miR-193b-3p;hsa-miR-222-5p;hsa-miR-27a-3p;hsa-miR-27b-3p;hsa-miR-590-3p;hsa-miR-627-5p;hsa-miR-944 | 13 | TGFBR3 | Sponge network | -3.785 | 0.00281 | -4.817 | 0 | 0.36 |
27 | RP11-166D19.1 |
hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-18a-3p;hsa-miR-18a-5p;hsa-miR-193a-3p;hsa-miR-193b-3p;hsa-miR-21-5p;hsa-miR-222-5p;hsa-miR-27a-3p;hsa-miR-27b-3p;hsa-miR-33a-3p;hsa-miR-484;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-627-5p;hsa-miR-944 | 18 | TGFBR3 | Sponge network | -4.209 | 2.0E-5 | -4.817 | 0 | 0.359 |
28 | ACVR2B-AS1 | hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-18a-5p;hsa-miR-193a-3p;hsa-miR-193b-3p;hsa-miR-21-5p;hsa-miR-222-5p;hsa-miR-27a-3p;hsa-miR-484;hsa-miR-590-3p | 10 | TGFBR3 | Sponge network | -2.253 | 0.00072 | -4.817 | 0 | 0.355 |
29 | CTB-92J24.3 |
hsa-let-7f-1-3p;hsa-miR-130b-3p;hsa-miR-17-5p;hsa-miR-188-5p;hsa-miR-18a-3p;hsa-miR-18a-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-21-3p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-301a-3p;hsa-miR-33a-3p;hsa-miR-589-3p | 14 | ESR1 | Sponge network | -7.226 | 0.0046 | -4.867 | 9.0E-5 | 0.355 |
30 | RP11-774O3.3 |
hsa-let-7f-1-3p;hsa-miR-107;hsa-miR-130b-3p;hsa-miR-130b-5p;hsa-miR-17-5p;hsa-miR-18a-3p;hsa-miR-18a-5p;hsa-miR-193a-3p;hsa-miR-193a-5p;hsa-miR-193b-3p;hsa-miR-21-3p;hsa-miR-31-5p;hsa-miR-32-3p;hsa-miR-324-5p;hsa-miR-330-3p;hsa-miR-590-3p;hsa-miR-629-3p;hsa-miR-7-5p | 18 | ESR1 | Sponge network | -1.989 | 0.00136 | -4.867 | 9.0E-5 | 0.351 |
31 | HAND2-AS1 |
hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-18a-3p;hsa-miR-18a-5p;hsa-miR-193a-3p;hsa-miR-193b-3p;hsa-miR-21-5p;hsa-miR-222-5p;hsa-miR-27a-3p;hsa-miR-33a-3p;hsa-miR-590-3p;hsa-miR-944 | 14 | TGFBR3 | Sponge network | -7.871 | 0 | -4.817 | 0 | 0.35 |
32 | MIR497HG |
hsa-let-7f-1-3p;hsa-miR-107;hsa-miR-130b-3p;hsa-miR-130b-5p;hsa-miR-17-5p;hsa-miR-188-5p;hsa-miR-18a-3p;hsa-miR-18a-5p;hsa-miR-193a-3p;hsa-miR-193a-5p;hsa-miR-193b-3p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-21-3p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-301a-3p;hsa-miR-31-5p;hsa-miR-324-5p;hsa-miR-33a-3p;hsa-miR-589-3p;hsa-miR-629-3p;hsa-miR-7-5p | 23 | ESR1 | Sponge network | -6.146 | 0.00024 | -4.867 | 9.0E-5 | 0.349 |
33 | RP11-150O12.3 |
hsa-let-7f-1-3p;hsa-miR-17-5p;hsa-miR-18a-3p;hsa-miR-18a-5p;hsa-miR-193a-3p;hsa-miR-193b-3p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-33a-3p;hsa-miR-629-3p;hsa-miR-9-3p | 13 | ESR1 | Sponge network | -4.03 | 0.14448 | -4.867 | 9.0E-5 | 0.348 |
34 | RP11-887P2.5 |
hsa-let-7f-1-3p;hsa-miR-107;hsa-miR-130b-3p;hsa-miR-130b-5p;hsa-miR-17-5p;hsa-miR-18a-5p;hsa-miR-193a-3p;hsa-miR-193a-5p;hsa-miR-193b-3p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-301a-3p;hsa-miR-33a-3p;hsa-miR-454-3p;hsa-miR-7-5p | 15 | ESR1 | Sponge network | -9.865 | 1.0E-5 | -4.867 | 9.0E-5 | 0.342 |
35 | AC016582.2 |
hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-18a-3p;hsa-miR-18a-5p;hsa-miR-193a-3p;hsa-miR-21-5p;hsa-miR-222-5p;hsa-miR-27a-3p;hsa-miR-590-3p | 11 | TGFBR3 | Sponge network | -5.41 | 0.03371 | -4.817 | 0 | 0.34 |
36 | NR2F1-AS1 |
hsa-miR-15a-5p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-18a-3p;hsa-miR-18a-5p;hsa-miR-193a-3p;hsa-miR-193b-3p;hsa-miR-21-5p;hsa-miR-222-5p;hsa-miR-27a-3p;hsa-miR-484;hsa-miR-590-3p | 12 | TGFBR3 | Sponge network | -2.961 | 0.00154 | -4.817 | 0 | 0.336 |
37 | MAGI2-AS3 |
hsa-let-7f-1-3p;hsa-miR-107;hsa-miR-130b-3p;hsa-miR-130b-5p;hsa-miR-17-5p;hsa-miR-188-5p;hsa-miR-18a-3p;hsa-miR-18a-5p;hsa-miR-193a-3p;hsa-miR-193a-5p;hsa-miR-193b-3p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-21-3p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-301a-3p;hsa-miR-31-5p;hsa-miR-32-3p;hsa-miR-324-5p;hsa-miR-33a-3p;hsa-miR-454-3p;hsa-miR-589-3p;hsa-miR-590-3p;hsa-miR-629-3p;hsa-miR-7-5p;hsa-miR-9-3p | 27 | ESR1 | Sponge network | -4.563 | 0 | -4.867 | 9.0E-5 | 0.335 |
38 | ADAMTS9-AS1 |
hsa-let-7f-1-3p;hsa-miR-107;hsa-miR-130b-3p;hsa-miR-130b-5p;hsa-miR-17-5p;hsa-miR-181b-5p;hsa-miR-188-5p;hsa-miR-18a-3p;hsa-miR-18a-5p;hsa-miR-193a-3p;hsa-miR-193a-5p;hsa-miR-193b-3p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-21-3p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-301a-3p;hsa-miR-31-5p;hsa-miR-324-5p;hsa-miR-454-3p;hsa-miR-589-3p;hsa-miR-590-3p;hsa-miR-629-3p;hsa-miR-7-5p | 25 | ESR1 | Sponge network | -8.573 | 0.00012 | -4.867 | 9.0E-5 | 0.335 |
39 | WDR86-AS1 | hsa-let-7f-1-3p;hsa-miR-130b-3p;hsa-miR-130b-5p;hsa-miR-17-5p;hsa-miR-188-5p;hsa-miR-18a-5p;hsa-miR-193a-3p;hsa-miR-193a-5p;hsa-miR-193b-3p;hsa-miR-19b-3p;hsa-miR-221-3p;hsa-miR-32-3p;hsa-miR-629-3p;hsa-miR-9-3p | 14 | ESR1 | Sponge network | -2.587 | 0.08454 | -4.867 | 9.0E-5 | 0.333 |
40 | RP11-887P2.5 |
hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-18a-5p;hsa-miR-193a-3p;hsa-miR-193b-3p;hsa-miR-21-5p;hsa-miR-222-5p;hsa-miR-27a-3p;hsa-miR-33a-3p;hsa-miR-590-5p;hsa-miR-944 | 13 | TGFBR3 | Sponge network | -9.865 | 1.0E-5 | -4.817 | 0 | 0.332 |
41 | HOTTIP |
hsa-miR-17-5p;hsa-miR-18a-3p;hsa-miR-18a-5p;hsa-miR-193b-3p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-21-3p;hsa-miR-32-3p;hsa-miR-589-3p;hsa-miR-590-3p;hsa-miR-7-5p | 11 | ESR1 | Sponge network | 0.232 | 0.87041 | -4.867 | 9.0E-5 | 0.33 |
42 | CTC-297N7.9 | hsa-miR-130b-3p;hsa-miR-18a-5p;hsa-miR-193a-3p;hsa-miR-193a-5p;hsa-miR-193b-3p;hsa-miR-21-3p;hsa-miR-301a-3p;hsa-miR-330-3p;hsa-miR-7-5p;hsa-miR-9-5p | 10 | ESR1 | Sponge network | -3.463 | 0.00542 | -4.867 | 9.0E-5 | 0.33 |
43 | RP11-532F6.3 | hsa-miR-130b-3p;hsa-miR-130b-5p;hsa-miR-17-5p;hsa-miR-188-5p;hsa-miR-18a-3p;hsa-miR-18a-5p;hsa-miR-193a-3p;hsa-miR-19b-3p;hsa-miR-301a-3p;hsa-miR-33a-3p;hsa-miR-629-3p;hsa-miR-9-5p | 12 | ESR1 | Sponge network | -2.663 | 0.00676 | -4.867 | 9.0E-5 | 0.329 |
44 | TRHDE-AS1 |
hsa-let-7f-1-3p;hsa-miR-107;hsa-miR-130b-3p;hsa-miR-17-5p;hsa-miR-188-5p;hsa-miR-18a-3p;hsa-miR-18a-5p;hsa-miR-193a-3p;hsa-miR-193a-5p;hsa-miR-193b-3p;hsa-miR-19b-3p;hsa-miR-21-3p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-31-5p;hsa-miR-32-3p;hsa-miR-330-3p;hsa-miR-33a-3p;hsa-miR-590-3p;hsa-miR-629-3p;hsa-miR-7-5p | 21 | ESR1 | Sponge network | -6.205 | 0.01165 | -4.867 | 9.0E-5 | 0.329 |
45 | CTD-2554C21.2 |
hsa-miR-130b-3p;hsa-miR-130b-5p;hsa-miR-17-5p;hsa-miR-18a-3p;hsa-miR-18a-5p;hsa-miR-193a-3p;hsa-miR-193a-5p;hsa-miR-193b-3p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-301a-3p;hsa-miR-629-3p;hsa-miR-7-5p | 13 | ESR1 | Sponge network | -6.968 | 0.00817 | -4.867 | 9.0E-5 | 0.326 |
46 | RP11-757G1.6 |
hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-18a-5p;hsa-miR-193a-3p;hsa-miR-193b-3p;hsa-miR-21-5p;hsa-miR-222-5p;hsa-miR-27a-3p;hsa-miR-27b-3p;hsa-miR-33a-3p;hsa-miR-590-3p;hsa-miR-627-5p;hsa-miR-944 | 13 | TGFBR3 | Sponge network | -2.705 | 0.04664 | -4.817 | 0 | 0.325 |
47 | MIR143HG |
hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-18a-3p;hsa-miR-18a-5p;hsa-miR-193a-3p;hsa-miR-193b-3p;hsa-miR-21-5p;hsa-miR-222-5p;hsa-miR-27a-3p;hsa-miR-33a-3p;hsa-miR-484;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-627-5p | 16 | TGFBR3 | Sponge network | -6.51 | 0 | -4.817 | 0 | 0.323 |
48 | EMX2OS |
hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-18a-3p;hsa-miR-18a-5p;hsa-miR-193a-3p;hsa-miR-193b-3p;hsa-miR-21-5p;hsa-miR-222-5p;hsa-miR-27a-3p;hsa-miR-27b-3p;hsa-miR-33a-3p;hsa-miR-484;hsa-miR-590-3p;hsa-miR-627-5p;hsa-miR-944 | 17 | TGFBR3 | Sponge network | -6.205 | 0.00015 | -4.817 | 0 | 0.319 |
49 | AC073283.4 |
hsa-let-7f-1-3p;hsa-miR-18a-3p;hsa-miR-18a-5p;hsa-miR-193a-3p;hsa-miR-193a-5p;hsa-miR-193b-3p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-31-5p;hsa-miR-7-5p;hsa-miR-9-3p | 11 | ESR1 | Sponge network | -2.801 | 0.08856 | -4.867 | 9.0E-5 | 0.316 |
50 | TPTEP1 |
hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-18a-3p;hsa-miR-18a-5p;hsa-miR-193a-3p;hsa-miR-193b-3p;hsa-miR-222-5p;hsa-miR-27a-3p;hsa-miR-484;hsa-miR-590-3p;hsa-miR-627-5p | 13 | TGFBR3 | Sponge network | -4.398 | 5.0E-5 | -4.817 | 0 | 0.316 |
51 | RP11-359B12.2 |
hsa-let-7f-1-3p;hsa-miR-130b-3p;hsa-miR-18a-3p;hsa-miR-18a-5p;hsa-miR-193a-3p;hsa-miR-193a-5p;hsa-miR-193b-3p;hsa-miR-21-3p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-330-3p;hsa-miR-590-3p;hsa-miR-629-3p | 13 | ESR1 | Sponge network | -2.094 | 0.00033 | -4.867 | 9.0E-5 | 0.314 |
52 | PGM5-AS1 | hsa-let-7f-1-3p;hsa-miR-107;hsa-miR-130b-3p;hsa-miR-130b-5p;hsa-miR-17-5p;hsa-miR-18a-3p;hsa-miR-193a-3p;hsa-miR-193a-5p;hsa-miR-193b-3p;hsa-miR-21-3p;hsa-miR-221-3p;hsa-miR-301a-3p;hsa-miR-33a-3p | 13 | ESR1 | Sponge network | -14.107 | 0 | -4.867 | 9.0E-5 | 0.311 |
53 | RP11-389C8.2 |
hsa-let-7f-1-3p;hsa-miR-107;hsa-miR-130b-3p;hsa-miR-130b-5p;hsa-miR-17-5p;hsa-miR-18a-3p;hsa-miR-18a-5p;hsa-miR-193a-3p;hsa-miR-193a-5p;hsa-miR-193b-3p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-21-3p;hsa-miR-301a-3p;hsa-miR-31-5p;hsa-miR-330-3p;hsa-miR-33a-3p;hsa-miR-589-3p;hsa-miR-629-3p | 19 | ESR1 | Sponge network | -3.089 | 2.0E-5 | -4.867 | 9.0E-5 | 0.309 |
54 | CTD-2314G24.2 | hsa-let-7f-1-3p;hsa-miR-18a-3p;hsa-miR-18a-5p;hsa-miR-193a-3p;hsa-miR-193b-3p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-32-3p;hsa-miR-590-3p;hsa-miR-629-3p;hsa-miR-7-5p;hsa-miR-9-3p | 12 | ESR1 | Sponge network | 2.041 | 0.35788 | -4.867 | 9.0E-5 | 0.306 |
55 | RP11-597D13.9 | hsa-miR-130b-3p;hsa-miR-130b-5p;hsa-miR-17-5p;hsa-miR-188-5p;hsa-miR-18a-3p;hsa-miR-18a-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-301a-3p;hsa-miR-31-5p;hsa-miR-32-3p;hsa-miR-33a-3p;hsa-miR-454-3p;hsa-miR-7-5p;hsa-miR-9-5p | 15 | ESR1 | Sponge network | -2.494 | 0.07597 | -4.867 | 9.0E-5 | 0.305 |
56 | RP11-981G7.6 | hsa-let-7f-1-3p;hsa-miR-130b-3p;hsa-miR-130b-5p;hsa-miR-17-5p;hsa-miR-18a-5p;hsa-miR-193a-3p;hsa-miR-193a-5p;hsa-miR-193b-3p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-324-5p;hsa-miR-590-3p;hsa-miR-629-3p;hsa-miR-7-5p | 14 | ESR1 | Sponge network | -0.726 | 0.44765 | -4.867 | 9.0E-5 | 0.303 |
57 | RP11-161M6.2 |
hsa-miR-130b-3p;hsa-miR-130b-5p;hsa-miR-17-5p;hsa-miR-18a-3p;hsa-miR-18a-5p;hsa-miR-193a-3p;hsa-miR-193a-5p;hsa-miR-193b-3p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-324-5p;hsa-miR-330-3p | 12 | ESR1 | Sponge network | -2.608 | 0.00296 | -4.867 | 9.0E-5 | 0.303 |
58 | MIR497HG |
hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-18a-3p;hsa-miR-18a-5p;hsa-miR-193a-3p;hsa-miR-193b-3p;hsa-miR-21-5p;hsa-miR-222-5p;hsa-miR-27a-3p;hsa-miR-33a-3p;hsa-miR-590-5p | 13 | TGFBR3 | Sponge network | -6.146 | 0.00024 | -4.817 | 0 | 0.303 |
59 | RP11-13K12.1 |
hsa-let-7f-1-3p;hsa-miR-17-5p;hsa-miR-18a-3p;hsa-miR-18a-5p;hsa-miR-193a-3p;hsa-miR-193a-5p;hsa-miR-193b-3p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-21-3p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-31-5p;hsa-miR-330-3p;hsa-miR-629-3p | 15 | ESR1 | Sponge network | -5.093 | 0.01151 | -4.867 | 9.0E-5 | 0.303 |
60 | FAM66C |
hsa-let-7f-1-3p;hsa-miR-130b-3p;hsa-miR-17-5p;hsa-miR-18a-3p;hsa-miR-18a-5p;hsa-miR-193a-3p;hsa-miR-193a-5p;hsa-miR-193b-3p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-33a-3p;hsa-miR-590-3p;hsa-miR-629-3p;hsa-miR-7-5p | 16 | ESR1 | Sponge network | -2.927 | 0.00012 | -4.867 | 9.0E-5 | 0.302 |
61 | RP11-326C3.11 | hsa-let-7f-1-3p;hsa-miR-130b-3p;hsa-miR-17-5p;hsa-miR-18a-5p;hsa-miR-193a-3p;hsa-miR-193a-5p;hsa-miR-193b-3p;hsa-miR-21-3p;hsa-miR-221-3p;hsa-miR-222-3p | 10 | ESR1 | Sponge network | -3.026 | 0 | -4.867 | 9.0E-5 | 0.3 |
62 | USP3-AS1 |
hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-18a-3p;hsa-miR-18a-5p;hsa-miR-193a-3p;hsa-miR-193b-3p;hsa-miR-21-5p;hsa-miR-222-5p;hsa-miR-27a-3p | 11 | TGFBR3 | Sponge network | -4.151 | 0 | -4.817 | 0 | 0.297 |
63 | RP11-116O18.1 |
hsa-let-7f-1-3p;hsa-miR-107;hsa-miR-130b-3p;hsa-miR-130b-5p;hsa-miR-17-5p;hsa-miR-18a-3p;hsa-miR-18a-5p;hsa-miR-193a-3p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-590-3p;hsa-miR-7-5p | 14 | ESR1 | Sponge network | -5.007 | 0.06008 | -4.867 | 9.0E-5 | 0.293 |
64 | LINC00899 | hsa-let-7f-1-3p;hsa-miR-107;hsa-miR-130b-3p;hsa-miR-18a-3p;hsa-miR-18a-5p;hsa-miR-193a-3p;hsa-miR-193a-5p;hsa-miR-21-3p;hsa-miR-324-5p;hsa-miR-590-3p;hsa-miR-7-5p | 11 | ESR1 | Sponge network | -1.597 | 0.00258 | -4.867 | 9.0E-5 | 0.292 |
65 | RP11-161M6.2 |
hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-18a-3p;hsa-miR-18a-5p;hsa-miR-193a-3p;hsa-miR-193b-3p;hsa-miR-21-5p;hsa-miR-222-5p;hsa-miR-27a-3p;hsa-miR-484 | 11 | TGFBR3 | Sponge network | -2.608 | 0.00296 | -4.817 | 0 | 0.292 |
66 | FAM66C |
hsa-miR-15a-5p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-18a-3p;hsa-miR-18a-5p;hsa-miR-193a-3p;hsa-miR-193b-3p;hsa-miR-21-5p;hsa-miR-222-5p;hsa-miR-27a-3p;hsa-miR-33a-3p;hsa-miR-484;hsa-miR-590-3p;hsa-miR-590-5p | 14 | TGFBR3 | Sponge network | -2.927 | 0.00012 | -4.817 | 0 | 0.292 |
67 | LINC00323 | hsa-miR-130b-5p;hsa-miR-17-5p;hsa-miR-18a-3p;hsa-miR-18a-5p;hsa-miR-193a-3p;hsa-miR-193b-3p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-301a-3p;hsa-miR-629-3p;hsa-miR-7-5p | 13 | ESR1 | Sponge network | -3.25 | 0.07329 | -4.867 | 9.0E-5 | 0.291 |
68 | RP11-774O3.3 |
hsa-miR-15b-5p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-18a-3p;hsa-miR-18a-5p;hsa-miR-193a-3p;hsa-miR-193b-3p;hsa-miR-21-5p;hsa-miR-222-5p;hsa-miR-27a-3p;hsa-miR-590-3p | 11 | TGFBR3 | Sponge network | -1.989 | 0.00136 | -4.817 | 0 | 0.288 |
69 | AC141928.1 | hsa-let-7f-1-3p;hsa-miR-17-5p;hsa-miR-18a-3p;hsa-miR-18a-5p;hsa-miR-193a-3p;hsa-miR-193a-5p;hsa-miR-193b-3p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-21-3p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-330-3p;hsa-miR-629-3p | 14 | ESR1 | Sponge network | -4.805 | 0.00102 | -4.867 | 9.0E-5 | 0.286 |
70 | RP11-389C8.2 |
hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-18a-3p;hsa-miR-18a-5p;hsa-miR-193a-3p;hsa-miR-193b-3p;hsa-miR-222-5p;hsa-miR-27a-3p;hsa-miR-33a-3p | 11 | TGFBR3 | Sponge network | -3.089 | 2.0E-5 | -4.817 | 0 | 0.284 |
71 | LINC00861 | hsa-miR-130b-3p;hsa-miR-130b-5p;hsa-miR-17-5p;hsa-miR-18a-3p;hsa-miR-18a-5p;hsa-miR-193a-3p;hsa-miR-193b-3p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-301a-3p;hsa-miR-31-5p;hsa-miR-33a-3p;hsa-miR-589-3p | 13 | ESR1 | Sponge network | 0.999 | 0.45301 | -4.867 | 9.0E-5 | 0.284 |
72 | RP11-983P16.4 |
hsa-miR-15a-5p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-18a-3p;hsa-miR-18a-5p;hsa-miR-193a-3p;hsa-miR-193b-3p;hsa-miR-21-5p;hsa-miR-222-5p;hsa-miR-27a-3p;hsa-miR-484 | 11 | TGFBR3 | Sponge network | -2.087 | 0.00021 | -4.817 | 0 | 0.281 |
73 | AC003090.1 |
hsa-let-7f-1-3p;hsa-miR-130b-3p;hsa-miR-130b-5p;hsa-miR-17-5p;hsa-miR-181b-5p;hsa-miR-18a-3p;hsa-miR-18a-5p;hsa-miR-193a-3p;hsa-miR-193a-5p;hsa-miR-193b-3p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-301a-3p;hsa-miR-31-5p;hsa-miR-330-3p;hsa-miR-590-3p;hsa-miR-629-3p | 19 | ESR1 | Sponge network | -7.817 | 0.00161 | -4.867 | 9.0E-5 | 0.28 |
74 | ADAMTS9-AS1 |
hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-18a-3p;hsa-miR-18a-5p;hsa-miR-193a-3p;hsa-miR-193b-3p;hsa-miR-21-5p;hsa-miR-222-5p;hsa-miR-27a-3p;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-627-5p | 14 | TGFBR3 | Sponge network | -8.573 | 0.00012 | -4.817 | 0 | 0.279 |
75 | RP11-130L8.1 |
hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-18a-5p;hsa-miR-193b-3p;hsa-miR-21-5p;hsa-miR-222-5p;hsa-miR-27a-3p;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-627-5p;hsa-miR-944 | 12 | TGFBR3 | Sponge network | -4.329 | 1.0E-5 | -4.817 | 0 | 0.278 |
76 | BZRAP1-AS1 | hsa-miR-130b-3p;hsa-miR-130b-5p;hsa-miR-17-5p;hsa-miR-18a-3p;hsa-miR-18a-5p;hsa-miR-193a-3p;hsa-miR-193a-5p;hsa-miR-193b-3p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-21-3p;hsa-miR-222-3p;hsa-miR-31-5p | 13 | ESR1 | Sponge network | -1.931 | 0.08861 | -4.867 | 9.0E-5 | 0.278 |
77 | ACTA2-AS1 |
hsa-let-7f-1-3p;hsa-miR-130b-3p;hsa-miR-130b-5p;hsa-miR-17-5p;hsa-miR-181b-5p;hsa-miR-188-5p;hsa-miR-18a-3p;hsa-miR-18a-5p;hsa-miR-193a-3p;hsa-miR-193b-3p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-21-3p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-301a-3p;hsa-miR-324-5p;hsa-miR-33a-3p;hsa-miR-454-3p;hsa-miR-589-3p;hsa-miR-590-3p;hsa-miR-7-5p | 22 | ESR1 | Sponge network | -6.142 | 0.00223 | -4.867 | 9.0E-5 | 0.277 |
78 | RP11-116O18.1 |
hsa-miR-15a-5p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-18a-3p;hsa-miR-18a-5p;hsa-miR-193a-3p;hsa-miR-21-5p;hsa-miR-222-5p;hsa-miR-27a-3p;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-944 | 12 | TGFBR3 | Sponge network | -5.007 | 0.06008 | -4.817 | 0 | 0.277 |
79 | PWAR6 |
hsa-let-7f-1-3p;hsa-miR-17-5p;hsa-miR-18a-3p;hsa-miR-18a-5p;hsa-miR-193a-3p;hsa-miR-193a-5p;hsa-miR-193b-3p;hsa-miR-19b-3p;hsa-miR-21-3p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-31-5p;hsa-miR-330-3p;hsa-miR-629-3p | 14 | ESR1 | Sponge network | -3.15 | 0.0082 | -4.867 | 9.0E-5 | 0.275 |
80 | CTD-2554C21.3 |
hsa-let-7f-1-3p;hsa-miR-130b-3p;hsa-miR-17-5p;hsa-miR-18a-3p;hsa-miR-18a-5p;hsa-miR-193a-3p;hsa-miR-193a-5p;hsa-miR-193b-3p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-301a-3p;hsa-miR-629-3p;hsa-miR-7-5p | 15 | ESR1 | Sponge network | -6.258 | 0.00703 | -4.867 | 9.0E-5 | 0.275 |
81 | RP11-822E23.8 |
hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-18a-3p;hsa-miR-18a-5p;hsa-miR-193a-3p;hsa-miR-193b-3p;hsa-miR-21-5p;hsa-miR-222-5p;hsa-miR-27a-3p;hsa-miR-484 | 12 | TGFBR3 | Sponge network | -8.351 | 0.00374 | -4.817 | 0 | 0.275 |
82 | A2M-AS1 | hsa-miR-15a-5p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-18a-5p;hsa-miR-193a-3p;hsa-miR-193b-3p;hsa-miR-21-5p;hsa-miR-222-5p;hsa-miR-27a-3p;hsa-miR-484;hsa-miR-590-3p;hsa-miR-627-5p | 12 | TGFBR3 | Sponge network | -5.049 | 0.03435 | -4.817 | 0 | 0.274 |
83 | RP11-13K12.5 | hsa-miR-130b-3p;hsa-miR-17-5p;hsa-miR-18a-5p;hsa-miR-193a-3p;hsa-miR-193a-5p;hsa-miR-193b-3p;hsa-miR-19b-3p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-629-3p | 10 | ESR1 | Sponge network | -5.713 | 0.01127 | -4.867 | 9.0E-5 | 0.274 |
84 | USP3-AS1 |
hsa-let-7f-1-3p;hsa-miR-107;hsa-miR-17-5p;hsa-miR-18a-3p;hsa-miR-18a-5p;hsa-miR-193a-3p;hsa-miR-193b-3p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-21-3p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-330-3p | 13 | ESR1 | Sponge network | -4.151 | 0 | -4.867 | 9.0E-5 | 0.272 |
85 | SOCS2-AS1 | hsa-miR-107;hsa-miR-130b-3p;hsa-miR-130b-5p;hsa-miR-17-5p;hsa-miR-188-5p;hsa-miR-18a-5p;hsa-miR-193a-3p;hsa-miR-21-3p;hsa-miR-324-5p;hsa-miR-33a-3p;hsa-miR-590-3p;hsa-miR-629-3p | 12 | ESR1 | Sponge network | -4.167 | 1.0E-5 | -4.867 | 9.0E-5 | 0.271 |
86 | ZNF667-AS1 |
hsa-let-7f-1-3p;hsa-miR-17-5p;hsa-miR-18a-3p;hsa-miR-18a-5p;hsa-miR-193a-3p;hsa-miR-193a-5p;hsa-miR-193b-3p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-21-3p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-301a-3p;hsa-miR-31-5p;hsa-miR-629-3p;hsa-miR-7-5p | 16 | ESR1 | Sponge network | -4.019 | 0.00137 | -4.867 | 9.0E-5 | 0.27 |
87 | CD27-AS1 | hsa-let-7f-1-3p;hsa-miR-107;hsa-miR-17-5p;hsa-miR-18a-3p;hsa-miR-18a-5p;hsa-miR-193a-5p;hsa-miR-193b-3p;hsa-miR-330-3p;hsa-miR-589-3p;hsa-miR-629-3p | 10 | ESR1 | Sponge network | -1.311 | 0.00574 | -4.867 | 9.0E-5 | 0.269 |
88 | DNM3OS |
hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-18a-3p;hsa-miR-18a-5p;hsa-miR-193a-3p;hsa-miR-193b-3p;hsa-miR-222-5p;hsa-miR-27a-3p;hsa-miR-33a-3p;hsa-miR-484;hsa-miR-590-3p;hsa-miR-590-5p | 14 | TGFBR3 | Sponge network | -3.933 | 0.00059 | -4.817 | 0 | 0.267 |
89 | RP11-983P16.4 |
hsa-let-7f-1-3p;hsa-miR-17-5p;hsa-miR-18a-3p;hsa-miR-18a-5p;hsa-miR-193a-3p;hsa-miR-193b-3p;hsa-miR-19b-3p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-31-5p;hsa-miR-629-3p | 11 | ESR1 | Sponge network | -2.087 | 0.00021 | -4.867 | 9.0E-5 | 0.264 |
90 | LINC00284 |
hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-18a-3p;hsa-miR-18a-5p;hsa-miR-193a-3p;hsa-miR-193b-3p;hsa-miR-222-5p;hsa-miR-27a-3p;hsa-miR-27b-3p;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-627-5p;hsa-miR-944 | 13 | TGFBR3 | Sponge network | -5.478 | 0.02716 | -4.817 | 0 | 0.263 |
91 | LINC00982 | hsa-let-7f-1-3p;hsa-miR-107;hsa-miR-130b-3p;hsa-miR-130b-5p;hsa-miR-17-5p;hsa-miR-18a-3p;hsa-miR-18a-5p;hsa-miR-193b-3p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-324-5p;hsa-miR-330-3p;hsa-miR-629-3p | 13 | ESR1 | Sponge network | -3.897 | 0.03858 | -4.867 | 9.0E-5 | 0.263 |
92 | CTD-2554C21.3 |
hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-18a-3p;hsa-miR-18a-5p;hsa-miR-193a-3p;hsa-miR-193b-3p;hsa-miR-21-5p;hsa-miR-222-5p;hsa-miR-27a-3p;hsa-miR-484 | 12 | TGFBR3 | Sponge network | -6.258 | 0.00703 | -4.817 | 0 | 0.258 |
93 | WT1-AS |
hsa-let-7f-1-3p;hsa-miR-107;hsa-miR-130b-3p;hsa-miR-130b-5p;hsa-miR-17-5p;hsa-miR-188-5p;hsa-miR-18a-3p;hsa-miR-18a-5p;hsa-miR-193a-3p;hsa-miR-193a-5p;hsa-miR-193b-3p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-222-3p;hsa-miR-301a-3p;hsa-miR-31-5p;hsa-miR-32-3p;hsa-miR-324-5p;hsa-miR-33a-3p;hsa-miR-589-3p;hsa-miR-590-3p;hsa-miR-629-3p;hsa-miR-9-3p;hsa-miR-9-5p | 24 | ESR1 | Sponge network | -6.875 | 2.0E-5 | -4.867 | 9.0E-5 | 0.258 |
94 | RP11-54O7.3 | hsa-let-7f-1-3p;hsa-miR-18a-3p;hsa-miR-193a-3p;hsa-miR-193b-3p;hsa-miR-21-3p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-31-5p;hsa-miR-330-3p;hsa-miR-629-3p | 10 | ESR1 | Sponge network | -2.864 | 0.01902 | -4.867 | 9.0E-5 | 0.257 |
95 | RP11-354E11.2 | hsa-miR-107;hsa-miR-130b-3p;hsa-miR-130b-5p;hsa-miR-18a-5p;hsa-miR-193b-3p;hsa-miR-19b-3p;hsa-miR-301a-3p;hsa-miR-324-5p;hsa-miR-33a-3p;hsa-miR-629-3p;hsa-miR-7-5p | 11 | ESR1 | Sponge network | -3.495 | 0.03784 | -4.867 | 9.0E-5 | 0.256 |
96 | DNM3OS |
hsa-let-7f-1-3p;hsa-miR-107;hsa-miR-130b-3p;hsa-miR-130b-5p;hsa-miR-17-5p;hsa-miR-188-5p;hsa-miR-18a-3p;hsa-miR-18a-5p;hsa-miR-193a-3p;hsa-miR-193a-5p;hsa-miR-193b-3p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-301a-3p;hsa-miR-32-3p;hsa-miR-330-3p;hsa-miR-33a-3p;hsa-miR-454-3p;hsa-miR-590-3p;hsa-miR-629-3p;hsa-miR-7-5p | 21 | ESR1 | Sponge network | -3.933 | 0.00059 | -4.867 | 9.0E-5 | 0.256 |
97 | LINC00461 | hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-193a-3p;hsa-miR-193b-3p;hsa-miR-21-5p;hsa-miR-222-5p;hsa-miR-27a-3p;hsa-miR-27b-3p;hsa-miR-944 | 11 | TGFBR3 | Sponge network | -2.019 | 0.3186 | -4.817 | 0 | 0.253 |
98 | ZNF582-AS1 |
hsa-let-7f-1-3p;hsa-miR-130b-3p;hsa-miR-130b-5p;hsa-miR-17-5p;hsa-miR-18a-3p;hsa-miR-18a-5p;hsa-miR-193a-3p;hsa-miR-193a-5p;hsa-miR-193b-3p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-301a-3p;hsa-miR-629-3p;hsa-miR-7-5p;hsa-miR-9-3p;hsa-miR-9-5p | 16 | ESR1 | Sponge network | -4.925 | 0.00112 | -4.867 | 9.0E-5 | 0.25 |